Podcasts about A1C

Episode 2861 - Vinnie Tortorich and Chris Shaffer welcome callers to discuss growing healthy eaters from a younger age and avoiding ultra-processed foods. https://vinnietortorich.com/2026/10/growing-healthy-eaters-episode-2861 PLEASE SUPPORT OUR SPONSORS Pure Vitamin Club Pure Coffee Club NSNG® Foods VILLA CAPPELLI EAT HAPPY KITCHEN YOU CAN WATCH THIS EPISODE ON YOUTUBE - @FitnessConfidential Podcast Vinnie's workout videos are available to purchase! Choose from a 2-day, 4-day, or 6-day workout–or buy all three at a discount! TO PURCHASE VINNIE'S WORKOUT VIDEOS, CLICK THIS LINK: https://vinnietortorich.com/workout Growing Healthy Eaters Greg is the first call-in guest. (4:00) He owns a small family restaurant. He and his family have been NSNG® for quite a while and love it. He lost approximately 70 pounds, and his A1c is no longer at diabetic levels. His kids are on board, too! Starting kids at a younger age can help keep them healthier and steer them away from junk-food habits. (18:00) Mika is the next caller. (29:30) She shared how she heard of NSNG®. Social media has a lot of misinformation. They discuss ultra-processed foods versus eating real food, like a steak. (41:00) People also misunderstand how long-duration, high-intensity activity affects the body. This type of activity can require a different approach than an average workout. (45:00) Mika also asks about fasting. (49:45) Vinnie doesn't care to fast because he likes to get protein into his body first thing in the morning. Check out the Aletha Hip HookTM that Vinnie uses to reduce pain and increase mobility: You can purchase your own through Vinnie's website here: https://vinnietortorich.com/hook Anna's products are now linked to PureVitamin Club's website. You can also purchase them under the "Food and Snacks" section. https://purevitaminclub.com/collections/food-and-snacks Vinnie hopes to add other products as well, all of which will be health-related. The NSNG® VIP GROUP is now closed again as of Sept. 30, 2026 Anna's next cookbook, Eat Happy Cocktail Hour, is filled with cocktails, mocktails, and appetizers and is available for pre-order right now. If you pre-order, you'll get bonus goodies! You can pre-order from a wide variety of booksellers at https://eathappycocktailhour.com/ Please save your receipt from wherever you pre-order; you'll need it for your bonuses! The physical release date is October 2026 You can book a consultation with Vinnie to get guidance on your goals. https://vinnietortorich.com/phone-consultation-2/ More News Serena has added some clothing and beauty product suggestions to Vinnie's Amazon Recommended Products link. Self-Care, Beauty, and Grooming Products That Actually Work! https://www.amazon.com/shop/vinnietortorich/list/3GPVU29UHHPMY?ref_=aipsflist Don't forget to check out Serena Scott Thomas on Days of Our Lives on Peacock. "Dirty Keto" is available on Amazon! You can purchase or rent it here.https://amzn.to/4d9agj1 Please watch, rate, and review it! Eat Happy Italian, Anna's second cookbook, is available! You can go to https://eathappyitalian.com You can order it from Vinnie's Book Club. https://amzn.to/3ucIXm Anna's recipes are in her cookbooks, on her website, and on Substack —they will spice up your day! https://annavocino.substack.com/ PURCHASE DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views it receives, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries

Your blood sugar can look perfectly normal for up to 14 years while insulin resistance quietly builds underneath. Dave Asprey and I get into why most doctors never test for it, why the restaurant "tallow fries" you ordered may not be what you think, and what happened to my cholesterol, gut bacteria, and inflammation markers after 90 straight days of carnivore. 93% of Americans are metabolically unhealthy. In 2018, that number was 88%. It's getting worse, not better. And most people won't find out until years after the damage starts, because the test that could catch it early usually isn't ordered. There's no medication for high insulin, so why check? In this conversation, Dave Asprey and I go after the things that keep people stuck as sugar burners: high insulin, seed oils hiding in "healthy" menu items, oxalates in so-called superfoods, and the idea that your metabolism slows down just because you got older. Spoiler: a 6,800-person study says otherwise. What if your labs look fine and you're still years into a metabolic problem? In this episode, I sit down with biohacker Dave Asprey to talk about why so many people are stuck burning sugar, and what it takes to get your metabolic flexibility back. We start with insulin, the marker most doctors skip, and why a fasting insulin over 6 may be a warning sign even when your glucose and A1C look normal. Dave and I also break down why high insulin, not salt, may be what's pushing your blood pressure up. From there, we get into seed oils and why "high smoke point" doesn't mean what most people think. A study on cooking oils found that the oils with the highest smoke points produced the most harmful polar compounds, while one oil most people are told not to cook with produced the least. Dave and I don't fully agree on this one, and that's part of the fun. I also share the results of my 90-day carnivore experiment, including full blood work, stool tests, and a review from a heart surgeon. My total cholesterol went from 300 to 450. What the rest of my markers showed may surprise you. Dave shares his own carnivore experiment, which went very differently, and we talk about where the upper limit should be. Plus: how Dave gave himself gout in three days, why almond flour gave me recurring styes, the right way to think about gut diversity, and why your metabolism isn't fast or slow, it's efficient or inefficient. If you care about insulin resistance, seed oils, keto, carnivore, fasting, gut health, or longevity, this one's for you. About Dave Asprey Dave Asprey is a biohacker, entrepreneur, and host of The Human Upgrade podcast. He founded Bulletproof and wrote The Bulletproof Diet, one of the first major books to bring intermittent fasting and keto to a mainstream audience. He's also the author of Heavily Meditated and the founder of Danger Coffee, and he's involved with Upgrade Labs. After losing 50 pounds in three months on keto, Dave spent the next decade experimenting to lose the last 50. That journey shaped his data-driven approach to metabolic flexibility, longevity, and biohacking. Health Disclaimer This podcast is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise, supplements, or health routine. FOLLOW DAVE ASPREY Website: Dave Asprey | Official Website About Dave Asprey: Biohacking, Longevity & Human Performance Instagram: Dave Asprey (@dave.asprey) YouTube: Dave Asprey FOLLOW BEN AZADIInstagram: Ben Azadi (@thebenazadi) • Instagram profileFacebook: Ben Azadi, FDN-PTikTok: Ben Azadi - Metabolic Freedom on TikTokLinkedIn: https://www.linkedin.com/in/benazadiYouTube: https://www.youtube.com/@BenAzadiWebsite: Ben Azadi

HRT side effects like bloating, weight gain, reflux and insomnia usually aren't caused by the hormone — they're caused by what the hormone exposes. Liz & Becca walk through the 3 A's of HRT: the labs to run first (SHBG, thyroid, A1c, fasting insulin, iron panel), how your gut, liver and gallbladder clear estrogen, why insulin resistance blocks hormones, and why low-and-slow beats pellets. Listen before you start.***→ Get LeelaQ Trusted quantum energy devices used in 86 countries, supporting balance and vitality through a more coherent energetic environment, even in the presence of everyday EMFs***Lets Connect:Connect with Liz: Instagram | YoutubeConnect with Becca: Instagram | YoutubeJoin our private community: FitMom Society***Have questions? Ask HereLooking for answers? Work with us***Want to win FitMom Mystery Box?Leave us Apple Review | Spotify Review***Mentioned in this episode:Leela Quantum TechTry the new Heal360 Advanced Frequency from LeelaQ, it's their most comprehensive wellness frequency system yet, designed to support cognitive wellness, recovery, emotional balance, energetic resilience, and a deeper energetic reset, and a more coherent energetic environment in today's rapidly evolving EMF landscape. It's available in wearable capsules in both brass and titanium, plus convenient frequency cards, making it easy to experience wherever life takes you. Visit leelaq.com and use FitMom code at checkout to get 10% off your next order. That's leelaq.com, code FitMom for 10% off

Rafe's birthday celebration continues, and the man has already eaten six or seven deviled eggs in the studio. So naturally, this episode about health and weight loss is off to a tremendous start.Blues broadcaster Chris Kerber joins the show to wish Rafe a happy birthday — and generously guesses that he's 38 instead of 48 — before Riz notices something considerably different about Kerbs: he's down about 40 pounds.Kerber explains how concerns over his A1C pushed him to change his eating habits rather than immediately go the medication route. He talks about eating better, managing portions, cutting down on late-night meals and adding simple habits like walking after eating. Riz is also down ten pounds, which is fantastic news until everyone starts talking about the spread at the Blues Media Open House.And THAT is where this daily comedy becomes a test of human willpower.Fried green tomato sandwiches. Burgers. Chicken. Bratwurst. German nachos. Beer cheese on potato chips. Chocolate popcorn. Walking tacos served in Doritos bags. And, because St. Louis apparently looked at cardiovascular health and said “not today,” a toasted ravioli burger.Riz somehow avoids eating everything in sight and describes the experience as Temptation Island. Frankly, that man deserves a medal.Kerber also previews the upcoming Blues season, talks about the young roster, the team's tough opening stretch and Logan Mailloux injuring his hand while throwing punches during a preseason game. Plus, Riz Show Night is coming back with a sweet satin jacket, although apparently some fantasy-book promotion is threatening our position atop the Blues theme-night food chain. We will not be dethroned without a completely unnecessary fight.Then the birthday food keeps coming.Brian from Le Bon Boucher arrives with coffee and a vanilla mousse cake for Rafe — immediately earning Rafe the nickname “Vanilla Moose” — along with bacon that becomes his birthday candle. Because regular candles apparently aren't enough when you've already eaten seven deviled eggs.Weight loss, hockey, birthday bacon, arena food and enough deviled eggs to make everyone in the studio nervous about the ventilation system. Just another completely responsible dose of daily comedy from The Rizzuto Show.And yes, Rafe keeps eating.That's commitment to daily comedy. Or gastrointestinal warfare. Could go either way.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

NOTE: This episode is intended for informational and entertainment purposes. Neither the host or guest are medical professionals, so this episode should not be construed as health advice. It not intended to treat, diagnose, or cure any health condition. N If you have specific concerns, please consult with your healthcare professional. Coach Bill Hogarty spent most of his life in peak condition, won twelve bodybuilding titles including Mr. California, and assumed he understood health. Then a shoulder injury sidelined him, he gained weight, and he learned what it feels like to be on the other side of the gym floor. That experience gave him something his training never had: empathy. Today he channels it into the Kids Diabetes Foundation, built on a conviction that childhood insulin resistance is preventable and that telling a struggling parent they are failing their kid will never work. In this candid conversation, Bill and Corinna trade notes as two people who have spent decades in health and fitness, and they do not always agree. They dig into why BMI is a poor marker while A1C and body composition tell a truer story, why muscle functions as an endocrine organ that protects us as we age, and why abstinence-based rules tend to backfire while moderation sticks. Corinna pushes back on the language of shame and on the toll that diet culture took on her own generation, and Bill meets her there. Along the way you will pick up practical, low-drama tactics: let your kid pick one thing from the produce aisle and build a meal around it, walk 30 minutes a day with someone you love, and learn one number that most doctors never order. CONNECT & SUPPORT CARE MORE BE BETTERSubstack: https://caremorebebetter.substack.comYouTube: https://www.youtube.com/c/caremorebebetterTikTok: https://www.tiktok.com/@caremorebebetterInstagram: https://www.instagram.com/caremorebebetterFacebook: https://www.facebook.com/CareMoreBeBetterLinkedIn: https://www.linkedin.com/company/care-more-be-betterCAUSE PARTNER: If you value open dialogue, sustainability, and social equity, I invite you to support our new cause partner —Prescott College. To learn more about this effort and to support the show, visit: https://caremorebebetter.com/support/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis. Regulatory decision expected 1st quarter 2027. Supported by phase 3 RCTs, 3000 pts -- LATITUDE PsO 3001 and 3002 clinical trials. https://t.co/o7oqxSXHSw Systematic review of 290 psoriasis pregnancies 211 live births (73%) finds biologic exposure (UST 241, 42 TNFi) during PREG assoc w/ favorable maternal/fetal outcomes. Only 24 cont either CZP or ADA throughout PREG. Rates of miscarriage, LBW, congenital anomalies, comparable w/ https://t.co/H5GLrvxwPv SELECT-PsA 2 subanalysis of 195 active PsA not responding to TNFi shows switching to upadacitinib 15 (vs PBO) was superior @wk 24 - ACR20 (58% vs 22%), ACR50 (38% vs 9.5%), ACR70 (22% vs 0%), MDA (24% vs 3%) & maintained thru wk 152. Switching MOAs makes sense! https://t.co/YEkZuQ95Mu Do biologic Rx lower risk of PsA? Metanalysis (15 studies, 124,138 psoriasis pts, 778K PYrs F/U), showed Biologic use assoc w/ lower risk of PsA (HR 0.54); best for IL-17i (0.65) & IL-12/23 or IL-23i (0.46) vs TNFi. IL-23i superior to IL-17i (HR 0.67) https://buff.ly/N4froBW OL study of tofacitinib in 20 juvenile DM pts w/ calcinosis cutis (11 boys; age 10.4 yrs; CC x 31 mos). Calcinosis assessed by CT scan showed decr Agatston score from 6,349 to 4,007. No SAE. https://t.co/UDLLwce3mp Metanalysis of Metabolic syndrome (MetS) in #SLE (65 articles, 11K pts). MetS prevalence 27% (higher in males (36 vs 27%). HCQ assoc w/ signif less MetS (OR 0.66), but more w/ CTX (1.39), AZA (1.25), MMF (1.13), but not steroids or MTX. MetS pts were older, obese, w/ high Chol & LDL https://buff.ly/VQNvSI9 TriNetX retrospective EHR study showed VTE in #RA not incr by taking JAKi. Pts undergoing THA/TKA Rx w/ JAKi (n 284) vs TNFi (n 288). VTE- 17 JAKi (6%) vs 11 TNFi (3.8%)- nonsignif incr (RR 1.57) https://t.co/OM5ipieQtr In 2022, Overweight & obesity affect 65.8% of Swiss PsA pts (vs gen pop.= 43%) and has increased since 2007. Obesity was assoc w/ elevated CRP (56% vs 37%), Inc Pt global assess (3.2 vs 2.8), & MD global (2.5 vs 2.1) & lower EQ-5D-3L(0.7 vs 0.8). https://t.co/xPoy4dgvlD Study of 119 Rheum pts on GLP-1 Rx (65% T2DM, 35% obesity; mean BMI 35). @ 12 mos wt loss −7.7 kg & 56% improved 1 BMI category. Signif decr in A1c, FBS, lipids, LDL, TG, ESR & CRP. GLP-1RAs useful cardiometabolic benefits https://t.co/fdNtvGu8Vb~ Estimated 7 million Americans (~1/3 US GLP1 Rxs) get GLP-1 drugs from online compounding source- but these are not FDA approved. They maybe cheaper, but dosing/quality is suspect. FDA needs to close the 503B loophole to outlaw these copycat Rxs https://buff.ly/xezDWaJ Data presented at 2027 ASMBS meeting showed betw 2020-2024, wt loss surgeries dropped 23%, from 230,000 in 2022 to 177,000 in 2024. Less than 1% of eligible pts are now having weight-loss surgery https://t.co/UnYIIBDdnz Together PsA 52 wk data (n 271): ACR50 plus 10% wt loss - 39.2% w/ Taltz & Zepbound vs 1.7% w/ Taltz alone. Together PsO trial results (n 274): PASI100 plus 10% wt loss - 30.6% w/ Taltz & Zepbound vs 4.4% w/ Taltz alone. https://t.co/27TBZyL8l1 FDA Approves Brepocitinib to Treat Dermatomyositis Necrotizing arteritis is rare w/ IgA Vasculitis (IgAV). Review compared 30 IgAV-NA to 257 adult IgAV & 196 PAN pts. Overall IgAV-NA is a severe IgAV phenotype with life-threatening complications & should prompt vascular imaging and intensified immunosuppression. IgAV-NA had more more GI bleeds, perforation, surgical abdomen, neuropathy, pancreatitis, livedo, more multi-organ involvement and mortality https://t.co/XdPbGX770D

In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Noah A. Kolb, MD, who served as the guest editor of the October 2026 Peripheral Nerve and Motor Neuron Disorders issue. They provide a preview of the issue, which publishes on October 2, 2026. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Kolb is a professor of neurological sciences at the Robert Larner College of Medicine at the University of Vermont in Burlington, Vermont. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Full episode transcript available here Dr. Jones: The human brain is incredibly complex. That's one of the reasons we like to study it and care for patients with neurologic problems. But to translate cognition into action, we need a functioning sensorimotor and autonomic peripheral nervous system. What do we do when those peripheral systems aren't working? Today, we're speaking with Dr. Noah Kolb, guest editor of our latest issue of Continuum on peripheral nerve and motor neuron disorders.   Dr. Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast.   Dr. Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr. Noah Kolb, who is Continuum's guest editor for our latest issue on peripheral nerve and motor neuron disorders. Dr. Kolb is a professor of neurology at the University of Vermont Larner College of Medicine in Burlington, Vermont, where he specializes in the care of patients with neuromuscular disorders, including patients with peripheral neuropathy and other immune-mediated neuromuscular diseases. Dr. Kolb, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners?   Dr. Kolb: Well, thank you very much for having me. Please call me Noah. I've been a longtime listener of Continuum, dating all the way back to when they came on CDs, so it's really a pleasure to be here. Like you said, I'm a neuromuscular doctor up in Vermont. I take care of the whole scope of neuromuscular disease, but kind of wear 3 different hats. I focus my research primarily in chemotherapy-induced neuropathy, but also do other diseases as well. Obviously, see patients clinically, and then I'm an educator as well, so I run the neurology clerkship and the acting AIs for the medical school. So, it's a fun job.   Dr. Jones: Well, thanks for sharing that little bit of history on Continuum Audio, Noah. I got to be honest with you, I don't know if I've ever seen a Continuum Audio CD. If anybody out there in the audience has a Continuum Audio CD, post a picture online and we'll like and share it. I wonder how many of those are still out there. I really appreciate you not just joining us today, Noah, but also putting together this really stellar issue, a very timely update and overview of peripheral nerve and motor neuron disorders. A lot of good topics for us to dig into today. What I'm going to do before we get into questions is ask our audience Continuum Audio's trivia question. Dr. Kolb and I were talking about this before we started recording here. So, the trivia question, just to frame it up a little bit, the transthyretin or TTR protein receives a lot of attention in neuromuscular medicine as the protein behind the most common causes of acquired and familial amyloidosis. But transthyretin is known in clinical settings by a different name and checked for an entirely different reason. So, the trivia question is, what is the other common name for transthyretin? Stick around, and we'll share the answer at the end of our interview. So, let's get right to it. Our listeners know that peripheral neuropathy is common, right? It affects 2 to 3 percent of the general population and 6 to 7 percent of patients who are older than 60. In your mind, Noah, what's the main thing you would like clinicians to know or do differently in the care of these patients?   Dr. Kolb: Yeah, that's a great question. I think it's something that we spend a lot of time teaching our residents and working with our fellows about is understanding the right workup for people presenting with neuropathy because it's very easy to overdo it with more labs and a broader workup than you need. So, when somebody presents with sort of a garden variety neuropathy that doesn't have red flags, the important things to order in terms of a workup are hemoglobin A1C, B12, and SPEP with IFE, potentially serum light chains, and some thyroid studies as well. Because those are really the most common reasons, and then to make sure that they ask the most important historical questions, like about alcohol use, et cetera. If you're going to find a cause for neuropathy, particularly if it's slowly progressive and sensory predominant, oftentimes the answer is found right in that basic workup.   Dr. Jones: Got it. And I think that's very well taken. And I think one of the questions that commonly comes up in the neuromuscular, but also in the broader neurology setting is, when you're evaluating a patient, especially an older patient who has a new onset length-dependent sensorimotor peripheral neuropathy, you've identified the neuropathy, and you're starting to consider what are those potential underlying disorders or risk factors that that neuropathy could be a warning sign of, right? So, you look for metabolic disease, B12 deficiency, paraproteinemia, et cetera. Where do you stop? In what settings do you do more expanded evaluations, genetic testing, et cetera?   Dr. Kolb: Yeah, and I think this kind of goes back a little bit to the last question where the primary focus of the workup that we do is driven by the most common causes. That's why hemoglobin A1C is so important. And so, thinking through what is likely to be the cause in the specific patient setting is kind of really critical. And again, if you don't have red flags, then the labs that we mentioned previously are probably sufficient in terms of a workup. But if there are any of the other red flags, it's really important specifically because there may be treatable causes of neuropathy or things that would affect the prognosis that'd be important to understand earlier so we can make sure we either engage the right therapies or do a broader diagnostic workup. An important part of that is understanding when to use EMG nerve conduction studies and when not to. So obviously, as a neuromuscular doc who does EMGs, I'm very fond of them. But we regularly see patients in our lab who perhaps don't need one. If somebody has a sensory predominant, slowly progressive neuropathy, particularly if you have an etiology, those patients usually don't need an EMG nerve conduction study. When it's asymmetric, when there's prominent weakness, when there's a lot of autonomic symptoms, those are the times when it can be a lot more informative and helpful to try to get an EMG nerve conduction study to see if we can get at what the underlying etiology is.   Dr. Jones: That's very helpful, Noah. Thank you. And so, let's think about a scenario that I think many of our listeners may have encountered in their practice. You're seeing a patient who has a somewhat rapidly progressive, painful neuropathy, which has some small fiber characteristics. They've got a little bit of autonomic dysfunction, and you worry about the possibility of amyloidosis. How do you approach that evaluation and treatment, and why is it important to think about that diagnosis?   Dr. Kolb: Yeah, that's great. It's important to think about that diagnosis because we now have good treatments for AL amyloid and for ATTR-based amyloid. So, because these are treatable disorders, it's really critical that you identify them. And the reality is it's not always straightforward making a diagnosis of amyloid. As you would with any other type of neuropathy, the workup is gonna begin with serum free light chains, SPEP, trying to see if there are any monoclonal gammopathies or elevation in light chains. But importantly, you need to think about what the next diagnostic steps are and understanding how likely those tests are to be abnormal in the setting of amyloid is important as well, because the easier to obtain tests don't have perfect sensitivity. So, once you've moved on kind of from the basic labs, we think about a fat aspirate or a skin biopsy to look and see if there's any evidence of amyloid. But if your clinical suspicion is high enough, it's important to move to a sural nerve biopsy and genetic testing. That's really the best way to confirm this diagnosis.   Dr. Jones: Very helpful. And obviously, that's not just academic, as it might have been at one point. This is something that we now have good disease-modifying therapies for, which leads to another question that I think our listeners may encounter in their practice. When you think about all the available gene tests in panels and other genomic tools that we have to investigate patients, when do you do a broad genetic evaluation for patients with neuropathy?   Dr. Kolb: Yeah, it's a good question. It depends partly on specifically what we're looking for. I think that as with many things in neurology, one of the reasons I got interested in it, and many people did, is we like doing detective work, and the history often lies in the examination and in our clinical history at the bedside. And for that reason, often just in getting the initial history with a patient, you start to get clues that there may be a hereditary component. Sometimes it's in the history where you're able to elicit a family history of disorder, and they may or may not know that the patient had neuropathy, but it may be that somebody walked funny later in life or somebody always complained of foot pain. Or it may simply be when a patient takes their shoes off, or in Vermont, they're wearing sandals, and you see that they have characteristic changes of a neuropathy that is much more longstanding than the patient even recognizes. That's often the case with some of these forms of hereditary neuropathy because sometimes they don't have a lot of pain. And so, you see those characteristic changes in the foot, and it cues you to the need for genetic testing. In my world where I see a lot of patients with chemotherapy-induced neuropathy, I also think about it in patients who seem to be specifically sensitive to neurotoxic agents, where they get a much worse neuropathy than you would expect with exposure to drug, and it's important to consider it in those times as well.   Dr. Jones: That's a great framing. I appreciate the way you put that. One of the great points in the issue is that patients who have sensory findings out of proportion to their sensory complaints, a lot of times it's worth thinking about a familial or genetic mechanism and then digging a little more into that family history, right?   Dr. Kolb: I agree.   Dr. Jones: Yeah. So, let's think of a different scenario. I know you do a lot of work with immune-mediated acquired neuropathies, and we're fortunate now, obviously, we have a lot of immunotherapy tools for the treatment of patients with neuropathies like chronic inflammatory demyelinating polyradiculoneuropathy. When it comes to CIDP, Noah, what's your initial approach to immunotherapy? That's one question. And another is, how do you incorporate some of the newer agents like efgartigimod? What's the role of that drug, or when do you go to rituximab or rozanolixizumab? Walk us through your approach to that.   Dr. Kolb: Yeah, so I think it depends a lot on what the clinical presentation looks like and kind of what the patient's preference is. In taking care of neuropathy patients for what's been quite a while now, you find that some patients have a differing comfort level with sort of the newer drugs like efgartigimod versus some of the therapies that have been around for years and years and are tried and true. So, we know, for instance, that plasmapheresis and IVIG work well. In certain cases, we use steroids because they can work well as well, but also have long-term toxicities that you want to be aware of. It's been really exciting to see that efgartigimod is a new therapy that's on the market, and it's been a really interesting space to be involved in, in neuromuscular medicine as some of these new disease-modifying therapies have come out. The trials for efgartigimod are really exciting, and it was very important to our field when efgartigimod became available. But there have been other trials that showed similar drugs weren't that effective, and there are many studies happening right now for complement inhibition with varying results. So, it's been sort of one of these hot topics in neuromuscular medicine, trying to see what these new therapies are and figuring out how to integrate them. I find that oftentimes with patients, we'll start with the tried and true therapies like IVIG or plasmapheresis, but don't hesitate to reach to efgartigimod, particularly if it's more convenient for the patient. I think the other important point to make, and this is addressed nicely throughout some of the manuscripts, is that there are specific instances where certain drugs are preferred. So, for instance, if you're seeing somebody with CIDP that has hard-to-treat symptoms, is not responding to the normal therapies that we use, it's important to think about whether they may have a paranodal form of CIDP, in which case we often reach for things like rituximab instead because it works better.   Dr. Jones: Outstanding. And so, I think that speaks to the importance of phenotyping, right? As we learn more about these acquired immune-mediated neuropathies, we're splitting, right? We're finding that the mechanisms are different in the tools that we have, the treatments are going to be more tailored, and more personalized to the patient. I think that's a great takeaway from the issue. So, Noah, you're in a unique position here, right? You're a world-renowned neuromuscular expert, and you have just edited a bunch of articles on neuromuscular medicine, peripheral nerve, motor neuron disorders written by experts in their respective fields. So, you have this bird's eye view of the specialty up to the minute, what's the latest. When you think about the entire issue, what would you say is the one topic that our readers or listeners could go to, to close the most important education gap in neuromuscular medicine?   Dr. Kolb: It's a great question. It's akin to asking who my favorite child is, of which is all of them, but I would say that when Amro Estino and Ben Becker submitted their manuscript on paraproteinemic neuropathies, after I read it, I wrote an email back to them just telling them how well I thought it was organized and that it really addressed an issue that constantly plagues trainees and practitioners, is how to deal with monoclonal gammopathies and paraproteinemic neuropathies. It's a nice example of what happens when you give smart people the creative space to organize something in a way that they think makes sense. I certainly learned about the topic reading that, and I think it'd be very high yield for people reading Continuum.   Dr. Jones: Totally agree. It's a wonderful article among many great articles, and that is a persistent education gap. So, I would direct our listeners to that article as well. You know, one of the things that I think about, you're an educator, I'm a clinician educator myself, thinking about the really interesting world of neuromuscular medicine, right? I have a significant part of my practice is in neuromuscular medicine and EMG, and I enjoy that very much. What do you think about trainees who might be interested in neuromuscular medicine, and they want to focus in it or pursue it as a career? How should they approach it? What does the training landscape look like from your perspective?   Dr. Kolb: Yeah, that's a great question and an important one. So, I think that the case to be made for neuromuscular medicine is strong. I talk with the residents and my medical students about this regularly, but I think it's hard to find a place in medicine where the field is evolving more rapidly than it is in neuromuscular medicine, which makes it sometimes hard to stay up to date with everything that's happening, but it also makes it really interesting. To have new medicines coming online for us to change the paradigm for the way we've been treating patients for years and years is very exciting, and I think that those changes are only going to grow. Part of the future of neuromuscular medicine really is going to be in better genetic testing and broader genetic therapies. When you think about hereditary neuropathy as an example, there are tons of emerging therapies that are in pre-clinical trials and some starting in clinical trials. And so, the future of neuromuscular medicine is going to be constantly evolving where we can now treat disorders that we couldn't treat before. I mean, the easiest example is SMA, where previously that was a universally fatal disease for infants, right? And now we have treatments that are very effective. And there are multiple diseases where we're starting to develop therapies like this, so it's really exciting. From a training perspective, there are lots of opportunities for residents as they approach fellowship. There are tons of great neuromuscular fellowships around the program. I would include UVM in there as well, where there's really a wide variety of neuromuscular things that you can learn. And it's a wide and varied field, so people are learning ultrasound, which has been an emerging part of neuromuscular medicine, EMG, electrodiagnostics, Botox, but then also treating autoimmune disorders, hereditary disorders. So, it's really quite a broad field, and you can really sort of super sub-specialize into different areas, which allows you to really focus if that's what you want to do.   Dr. Jones: So now it's time for the answer to our Continuum Audio Trivia question. Just to remind our listeners, what is the other common name for transthyretin? We think about transthyretin a lot, as Noah mentioned, in terms of acquired and familial amyloidosis, but what is the other name for it? Dr. Kolb, do you want to give the answer to our audience?   Dr. Kolb: That would be prealbumin.   Dr. Jones: Prealbumin. Again, we talk about transthyretin all the time because of the neurologic and cardiac presentations of ATTR wild type and variant transthyretin amyloidosis. But the protein itself, in the non-pathologic setting, in the non-amyloid setting, is a stable tetramer. Its normal function is to transport thyroxine and vitamin A throughout the body, but it also has a relatively short half-life. And on electrophoretic gels, it segregates near the albumin band, and therefore, for a long time was just called prealbumin because it was near the albumin band. And because of that short half-life, it's used as a rough or loose marker of nutritional status. So, all those times when I was a medical student and a resident ordering prealbumin to assess nutritional status, I was really checking transthyretin, and I had no idea.   Dr. Jones: All right. So, Dr. Kolb, I really want to thank you for joining us. Thank you for such an outstanding conversation about peripheral nerve and motor neuron disease in the latest issue of Continuum. I learned a lot reading this issue. I learned a lot in our conversation today. I hope our listeners did too. I'm really grateful for your hard work taking on this issue, which I think will come in handy not only to our more junior listeners and subscribers, but also, our more experienced listeners as well.   Dr. Kolb: Thanks for the opportunity to chat with you. I'm excited for the public to see the Continuum manuscripts. I think there's a lot to learn, and it's an exciting issue.   Dr. Jones: I agree. Again, today we've been speaking with Dr. Noah Kolb, guest editor of Continuum's most recent issue on peripheral nerve and motor neuron disorders. Please check it out, and thank you to our listeners for joining today.   Dr. Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.

Pregnancy with type 1 diabetes comes with tighter blood sugar targets, changing insulin needs, more appointments, and a whole new level of attention to your diabetes. But what does it actually look like to go through the entire experience?In this episode, Lauren sits down with Risely Coach Katerina Harmon, who recently welcomed her daughter, Lydia, to talk through her experience from preparing for pregnancy all the way through labor, delivery, breastfeeding, and the first few months postpartum.Katerina went into pregnancy feeling confident in her diabetes management, with an A1C of 5.9 and months of preparation behind her. But even with that foundation, there was plenty she had to figure out along the way, from insulin needs that changed dramatically throughout pregnancy to advocating for herself, preparing for labor and delivery, and finding a new rhythm with T1D once Lydia was here.WHAT WE COVER:What Katerina did months before trying to conceive to prepare her blood sugars for pregnancyHow her insulin needs changed throughout each trimesterWhy knowing how to recognize patterns and confidently adjust insulin became so importantKaterina's experience using manual mode during much of her pregnancyAdvocating for yourself with your endocrinology, MFM, and OB teamsHow Katerina prepared her husband to help manage her T1D during laborHer 44-hour labor, induction, epidural, and four and a half hours of pushingWhat happened to her insulin needs after giving birthBreastfeeding with T1D and navigating postpartum lowsWhat Katerina wishes women with T1D knew before beginning pregnancy prepIf pregnancy is something you're thinking about in the next year or two, you're actively preparing, or you're already pregnant, this conversation gives you an honest look at what the experience can actually look like with type 1 diabetes.WHAT'S NEXT:

What happens when you trade processed bread for freshly-milled whole grains? In this inspiring episode, Sue Becker reads email from two women who have shared remarkable health journeys—including improved cholesterol, triglycerides, A1C, energy, digestion, and more—and how freshly milled wheat became a game changer for their families. Their stories are a powerful reminder of the nourishment found in real food and the importance of taking an active role in your health journey. Tune in and be encouraged by what can happen when you discover the benefits of REAL BREAD! Topics in this episode include: cholesterol, triglycerides, A1C, energy, digestion LISTEN NOW

MAPS Abs and Butt: https://mapsabsandbutt.com Code: LAUNCH for 40% off. Includes Butt Building Diet Guide, Women's Supplement Guide, at-home dumbbell version and a free second program at checkout (Muscle Mommy or Muscle Mommy 15). Dr. Stephen Cabral returns to break down the seven blood markers that predict heart disease better than cholesterol. He explains what each one means, what optimal ranges look like versus what standard lab ranges say, and how to improve each one through diet, exercise and targeted supplementation. He then reveals the guys' individual omega-6 to omega-3 inflammation test results live on air — comparing where they were two years ago to where they are now and why Doug is the clear winner. They also cover the cyclosporiasis parasite outbreak in lettuce, natural parasite treatment protocols, PDE5 inhibitors for cardiovascular health, why glucose monitors are overused in athletic populations, and whether rancid fish oil is a real problem and how to avoid it. 50% Off Inflammation Test https://stephencabral.com/inflammation    SPONSORS  Zbiotics Pre-Alcohol: https://zbiotics.com/MINDPUMP26 Code: MINDPUMP26 for 15% off first purchase. World's first genetically engineered probiotic. Breaks down acetaldehyde in the gut before it causes next-day issues.   GUEST LINKS Dr. Stephen Cabral: https://stephencabral.com Inflammation test: https://stephencabral.com/inflammation   LINKS Mind Pump Store: https://mindpumpstore.com Maps Fitness Products: https://mapsfitnessproducts.com Instagram: @mindpumpmedia   0:00 - Intro 3:03 - 7 blood markers that predict heart disease better than cholesterol 4:38 - Marker 1: ApoB — the most important predictor of arterial plaque that all cardiologists now look at 8:12 - Marker 2: High sensitivity CRP — how chronic inflammation embeds cholesterol into arterial tissue 10:05 - Marker 3: Homocysteine — methylation issues, optimal range and the B vitamin fix 12:30 - Marker 4: Total cholesterol to HDL ratio — why a 3 to 1 ratio is the target 14:57 - Marker 5: Triglycerides to HDL ratio — the metabolic disease predictor most doctors ignore 20:13 - Marker 6: Hemoglobin A1C — why athletes with spiking glucose still have perfect A1C 25:03 - Marker 7: Omega-6 to omega-3 ratio — 90% cardiovascular death risk reduction above 9% saturation 30:49 - The guys' live omega inflammation test results — two years of data revealed 35:08 - Adam's result — dropped from 7.3 to 6.0 without supplementing 36:23 - Sal's result — improved from 7.8 to 4.9 with sardines and omegas 37:55 - Doug's result — already at 3.7 and winning the whole room 43:18 - How to choose a quality fish oil — cold processed, third party tested, no mercury 46:28 - When to take vitamin D vs omega-3 and why timing matters 48:01 - Cyclosporiasis parasite outbreak and natural parasite treatment protocols 52:12 - Dr. Cabral's free at-home inflammation test — how to get it

Katie Beth Hand had an islet cell transplant in January. She has been off insulin since March 3 with an A1c of 4.9. Six months later, she returns to describe what it actually feels like. twiist - A different type of insulin pump has arrived ABLEnow save for today's needs or invest for tomorrow Eversense CGM MiniMed Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

What is normal insulin? Learn what fasting insulin levels can reveal about insulin resistance, how to lower fasting insulin, how to decode A1C levels, and what you can learn to help prevent type 2 diabetes.

What if perimenopause isn't simply changing your hormones, but revealing everything your body has been compensating for for years? In this episode, Dr. Mariza sits down with integrative medicine physician and women's health expert Dr. Taz Bhatia for an incredibly personal conversation about what happens when the strategies that helped high-functioning women push through for decades suddenly stop working. Dr. Taz shares how her own perimenopause began with incredibly heavy periods, fatigue, anemia, hair loss, mood changes, and unexpected weight gain. But one of her biggest surprises came later: as progesterone and estrogen declined, her blood sugar, insulin, cholesterol, A1C, and liver enzymes began creeping upward, revealing just how interconnected hormones and metabolic health really are. They also explore the emotional transformation of midlife: letting go of people-pleasing, protecting your energy, releasing the need to be the “good girl,” and becoming clearer about who you are and what deserves your attention. Listen now to rethink perimenopause as an opportunity to understand your body, protect your health, and step powerfully into what comes next. DR. TAZ BHATIA Dr. Taz Bhatia is a board-certified integrative medicine physician, women's health expert, and bestselling author of several books, including The Hormone Shift. Her work explores the connections between hormones, metabolism, stress, nutrition, and whole-body health. Through her Whole Plus clinics and podcast, Dr. Taz advocates for a more collaborative approach to women's health that looks beyond symptoms to cognitive, metabolic, cardiovascular, bone, mental, and hormonal health. IN THIS EPISODE How extremely heavy periods became Dr. Taz's first undeniable sign of perimenopause Why weight gain in midlife isn't necessarily something women simply have to accept How estrogen and progesterone shifts can intersect with blood sugar, insulin, cholesterol, and visceral fat Why the “silent” cardiometabolic changes of menopause deserve more attention Why your body may stop tolerating the stress, sleep debt, and depletion you once pushed through How perimenopause helped Dr. Taz stop people-pleasing and build stronger boundaries Why knowing your own patterns and tracking changes can help you advocate for yourself How midlife can become an opportunity to redefine your identity, purpose, and power QUOTES Perimenopause is really where women come into their own.” “These are not my battles. This is not my fight.” “We gotta redefine what fine is.” RESOURCES MENTIONED Find inspiration, connection, and meaningful reads: Join my Soulful Shelf Book Club (no cost) here: https://drmariza.com/bookclub Join my brand-new Substack: for the woman everyone depends on who is wondering why everything feels harder in midlife: https://drmariza.substack.com/ The Hormone Shift by Dr. Taz Bhatia: https://amzn.to/4xJ5VfK The Superwoman Rx by Dr. Taz Bhatia: https://amzn.to/4hHkZpn Dr. Taz Website: https://doctortaz.com/ Dr. Taz Instagram Hol+ Wellness Podcast RELATED EPISODES  775: Wide Awake at 3 A.M.? What's Really Disrupting Your Sleep in Midlife with Morgan Adams 774: Training for Your Grandma Self: How to Build a Body That Lasts 771: Beyond Hot Flashes: The 103 Symptoms of Perimenopause No One Talks About with Andrea Donsky 769: Is It Perimenopause or Something Else? How to Finally Connect the Dots with Dr. Mariza

In this episode, Lauren sits down with Dara Melnick, a licensed therapist who has lived with T1D for 38 years, to talk about the side of “good” diabetes management beyond the numbers.Dara spent years trying to keep her numbers as perfect as possible. She tested her blood sugar up to 30 times a day before CGMs, developed strict rules around food, and eventually stopped eating breakfast to avoid the spike. Her A1C looked great, but managing T1D was exhausting. Through Risely coaching, Dara learned how to loosen those rules without sacrificing the blood sugars she had worked so hard for. Today, she has a 5.7 A1C while eating based on what her body is asking for, salmon and sourdough or Cheez-Its and pretzels.Lauren and Dara also get into what 38 years with T1D has taught Dara as a therapist, a mom, and a woman, from using the “power of the pause” when diabetes goes sideways to why asking for help can be one of the most powerful things you do for yourself.WHAT WE COVER:How trying to keep her blood sugar “perfect” led Dara to a 6.1 A1C, testing up to 30 times a day, and eventually skipping breakfast altogetherThe Risely secrets that helped Dara go from strict food rules to a 5.7 A1C while eating what she craved, when she craved itWhen “good” diabetes management crosses the line into diabetes controlling your lifeWhat led Dara to ask for help even though she's a licensed therapist who'd managed T1D for decadesThe “power of the pause” and how Dara uses it to respond instead of react to CGM readingsWhat T1D has taught Dara about raising her 10 and 13-year-old kids, including the lesson they learned when she suddenly went low on a family hikeWHAT'S NEXT:

This week on On The Pen, The Weekly Dose Podcast, retatrutide heads into a major federal court fight as the Department of Justice gives FDA fresh legal ammunition just days before oral argument.At the same time, FDA is escalating its scrutiny of mass GLP-1 compounding, with a warning letter to Empower Pharmacy that could have major implications for semaglutide, tirzepatide, telehealth prescribing, and patient access.We also break down Viking Therapeutics' new VK2735 maintenance data, including early weight-loss numbers that are starting to draw retatrutide comparisons and the possibility of every-other-week or even monthly maintenance dosing.Plus, Roche's enicepatide, formerly CT-388, just posted a 2.65 percentage-point A1C reduction and 15.5% weight loss in people with type 2 diabetes and obesity, raising new questions about how competitive the next generation of GLP-1/GIP drugs may become.This episode is about more than one drug. It is about where obesity medicine is heading, who gets access, how regulators are drawing the lines, and why the next few years may look very different from the market we know today.Https://www.onthepen.comHttps://www.otplinks.com

Johan sits down with Caitlin Jones, a functional nutritionist who has spent the last three years focused on blood work, blood sugar regulation and insulin sensitivity, including reversing pre- and type 2 diabetes. They open with the CGM-and-oatmeal posts that circulate online: a blood sugar rise after a meal is normal, and what actually matters is the rest of the meal and whether the basics are in place. Caitlin shares how she was diagnosed pre-diabetic while powerlifting and reversed it with a calorie deficit, lower carbs, steady protein, walks after meals and the same lifting she was already doing. You'll walk away with a plain-language picture of how blood sugar rises and falls, what an unbalanced eating pattern does to that baseline over time, and where labs, muscle and maybe even a GLP-1 actually fit.More from Caitlin:https://www.caitlinjcoaching.com/https://www.instagram.com/caitlin.j.coaching/In this episodeWhy the CGM-and-oatmeal posts show something normal: a rise after carbs is expected, and nobody eats a carb by itself.Caitlin's story: diagnosed pre-diabetic about four years ago while powerlifting on 370 grams of carbs a day, fasting blood sugar in the 140s, 192 pounds at 5'2".Over-eating and under-eating can feel the same in the body: tired, poor sleep, poor recovery.The protein craze, fortified everything, and why so many clients come in over-eating protein and under-eating carbs.How her parents taught balance without making it a thing: soda or ice cream at team dinners, never both.Blood sugar 101 in plain language: it rises after eating, insulin brings it down, and an unbalanced pattern slowly pushes the baseline up.Type 2 as a lifestyle condition, and why "you don't look pre-diabetic" is not a diagnosis. The stick-thin client whose doctor doubted it until a week of testing said otherwise.How Caitlin reversed hers: a deficit, lower carbs, protein held, walks after meals, same lifting. Her transparent take on an eight-month semaglutide microdose as a tool, not the reason it worked.Why people who skip the basics on a GLP-1 tend to regain, and what she does with them next.What she checks first with a new client: three to five days of food logs (under-reporting, hidden fats, the coffee), then A1C and fasted insulin.Why muscle is one of the best blood sugar tools you have: the sugar has somewhere to go.The hardest part: the habits people didn't know were habits, and eating for a purpose.A little hunger is normal and doesn't need fixing right now.Intuitive eating as "the PhD of eating": the long-term goal, not the method.- - - - -Talking Nutrition is brought to you by Odyssey Coaching Systems.Website and free resources: https://odysseycoachingsystems.co/Follow Johan on Instagram: https://www.instagram.com/johanvesters_ocs/Apply for coaching: https://odysseycoachingsystems.co/coaching-application

Your blood sugar isn't just about sugar — it's tangled up with your gut, your immune system, and how your whole metabolism runs. This episode pulls together three conversations that build on each other, from one guy's simple fix to the bigger picture behind it all — meet your three experts below. Most people with type 2 diabetes are told it's a forever sentence. Chris Reade was one of them. In 2017, his A1C hit 9.1 with zero warning. He refused medication, did the research, and built a food system around the science of soluble fiber. Six months later, his A1C was 5.5. Seven years later, it has never gone back up. Danielle Hamilton is a Functional Nutritional Therapy Practitioner & Restorative Wellness Practitioner who specializes in blood sugar regulation & digestion. She became interested in blood sugar issues when she learned that Insulin Resistance was at the root of her PCOS. She was able to reverse her PCOS, cystic acne, PMS & weight loss resistance by reversing Insulin Resistance. Joel Greene is the very first gut-health protocol teacher, the original biohacker that utilizes the immune system and the family of insulin hormones to create lasting health. Joel has spoken on other top podcasts such as Ben Greenfield's Life and Cynthia Thurlow's Everyday Wellness.  In this episode, you'll hear three experts connect the dots between blood sugar, gut health, and metabolism — starting with one guy's simple fix and ending with the bigger picture behind it all. RESOURCES: Learn more about Chris Reade here: https://www.beatingdiabetes.us/ Chris Reade's Instagram: @beatingdiabetesus Check out the full conversation with Chris here: https://www.taragarrison.com/blog/chrisreade  Learn more about Danielle here: http://daniellehamiltonhealth.com Danielle Hamilton's Instagram: @daniellehamiltonhealth Check out the full conversation with Danielle here: https://www.taragarrison.com/blog/daniellehamilton Joel Greene's Instagram: @realjoelgreene Check out the full conversation with Joel here: https://www.taragarrison.com/blog/joelgreene   CHAPTERS: 00:00 – Intro: the blood sugar & metabolic health expert stack 01:39 – Chris on his diabetes diagnosis 03:46 – The shock: A1C jumps from normal to 9.3 06:04 – What caused it: a parasite that wrecked his gut biome 09:53 – The research: soluble fiber studies since the 1970s 12:33 – Cutting sugar, ramping fiber, and an unplanned 25-lb loss 14:35 – Danielle's wake-up call: the PCOS/diabetes connection 16:05 – The "personality traits" that were really blood sugar crashes 17:00 – Recognizing a crash: brain fog, mood, the Snickers test 22:14 – How blood sugar works and the insulin resistance spiral 27:05 – Digestion mechanics: chewing and stomach acid 31:01 – Bile, fat digestion, leaky gut, and practical fixes 34:37 – Joel's framework: three metabolisms, not one 36:04 – Immune cell metabolism's link to fat, obesity, and cancer 38:28 – Why sugar isn't "just a calorie": Warburg metabolism 42:40 – The gut-immune axis: your body's biggest immune hotspot 44:46 – Bifidobacteria and Akkermansia: the gut-immune balance 48:18 – Sugar, extreme diets, and why they backfire long term   WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: CHECK OUT HIGHER FITNESS APP: https://app.taragarrison.com/ INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

Broadcast from KSQD, Santa Cruz on 9-17-2026: Dr. Dawn opens with a primer on kidney function: their embryonic origin adjacent to the gonads, their central role in blood pressure regulation (retaining fluid in hemorrhage but paradoxically worsening heart failure), erythropoietin production (both an athletic doping agent and a mechanism by which severe sleep apnea can cause stroke-risk polycythemia), acid-base balance via bicarbonate, and nitrogen waste removal including uric acid. The U.S. waiting list holds 95,492 people needing kidney transplants—88% of all organ waitlist patients—against only 27,500 annual donations, with 12-13 people dying daily on the list. Dr. Dawn walks through a Wired magazine analysis of paid donation, noting Iran is the only country with a legal regulated kidney market (Iranian citizens only, with a waiting list of donors and compensation around two months of median income). She frames the ethical debate: current U.S. altruistic donation implicitly rewards those with money and social networks who can afford time off, while poorer populations bear disproportionate end-stage renal disease burden. Proposed compensation alternatives include lifetime congressional-quality health insurance, student loan forgiveness, six-month waiting periods for informed consent, and 20-year payout structures. Donation mortality risk is comparable to childbirth—several-fold lower than logging. Tim Andrews became the first patient to receive a genetically modified pig kidney as a bridge to human transplant, sustaining him 271 days until a human kidney became available (the pig kidney ultimately lost to pyelonephritis, not rejection). eGenesis used CRISPR to delete three highly antigenic pig genes—GGTA1 (which produces alpha-gal, the tick-transmitted meat allergy trigger), CMAH, and one other—along with porcine endogenous retroviruses, and added seven human genes for coagulation compatibility and anti-inflammation. Dr. Dawn notes the animal welfare implications of farming 50,000 modified pigs annually and unknown long-term graft survival. An emailer asks about direct-to-consumer full-body MRI screening. Dr. Dawn explains MRI's advantages (no ionizing radiation, no kidney-toxic contrast) but emphasizes false positive harms: indeterminate findings that require invasive follow-up biopsies for lesions unlikely to be lethal, and the psychological burden of "ghost" diagnoses. Whole-body MRI also poorly evaluates lungs, intestines, and breasts (different scan parameters required). She recommends full-body MRI only for high-risk cancer predisposition syndromes like Lynch syndrome, BRCA 1/2, and Li-Fraumeni. Dr. Dawn debunks the "seed" model of probiotic capsules: strains taken for six months typically disappear from the gut within a month of stopping. Much of probiotic benefit comes from dead bacteria—autoclaved cell walls remain biologically active with antibacterial effects. Her clinical protocol uses 200-300 billion CFU four times daily to treat traveler's diarrhea, avoiding Cipro's tendon toxicity. For antibiotic-associated C. difficile prevention, Saccharomyces boulardii plus Bifidobacterium and Lactobacillus have double-blind placebo-controlled support when taken between antibiotic doses and for a week afterward. A caller with type 2 diabetes describes suspected treatment-induced neuropathy following rapid A1c reduction from 10.2 to a GMI of 5.8. She has burning, electric tingling, and unexplained deep muscle-soreness sensations, mostly proximal in the left leg with recent right-leg involvement, and pregabalin isn't helping. Dr. Dawn distinguishes small-fiber neuropathy (temperature-related, patchy, requires skin biopsy for diagnosis—EMG and nerve conduction won't show it) from large-fiber neuropathy (symmetric, ascending from toes). The proximal top-down distribution suggests small-fiber involvement. She recommends functional-medicine adjuncts: methylated B12 2,000 mcg, methylated folate 2,000 mcg, and alpha-lipoic acid 300 mg twice daily for three months. She also recommends a provoked heavy-metals urine test to rule out copper or other neurotoxic exposure. Dr. Dawn closes with the fiber recommendation of 14 grams per 1,000 calories (correcting an earlier misstatement of 14g total per day) and emphasizes that a diverse plant-based diet—fruits, vegetables, root vegetables, beans, nuts—does more for microbiome health than any capsule.

Send us Fan MailInsulin Resistance: The Metabolic Warning Sign You May Be MissingInsulin resistance can develop long before type 2 diabetes—and many people don't know they have it. In this episode of the Mindfully Integrative Show, we break down what insulin resistance means, how insulin and blood sugar work together, common risk factors, and why metabolic health involves much more than the number on the scale.You'll also learn:What insulin resistance actually meansHow insulin resistance relates to prediabetesImportant metabolic numbers to knowWhy muscle, movement, nutrition, and sleep matterWhat the landmark Diabetes Prevention Program taught usSimple steps you can start using to support better metabolic healthKey takeaway: Metabolic health isn't about perfection. Small, sustainable changes in movement, nutrition, sleep, and body composition can meaningfully influence long-term health.

What if the brain's future is shaped by more than genetics and age? In this episode of Take Back Your Health®, Dr. Amy Myers reconnects with neurologist and author Dr. David Perlmutter to discuss the brain's immune system, metabolism, inflammation, and the lifestyle factors that may influence cognitive health. Dr. Perlmutter joins Dr. Amy to discuss his newest book, Brain Defenders, and the role of microglia, the brain's immune cells. They explore immunometabolism, blood sugar, sleep, exercise, diet, perimenopausal hormone changes, APOE4, and why brain-health work may need to begin long before symptoms appear. What you'll learn in this episode: How microglia can shift between supportive and more destructive states Why blood sugar, insulin, A1C, inflammation, sleep, and exercise matter for brain health What Dr. Perlmutter discusses about P-tau217, homocysteine, and related markers Why cognitive-health habits may need to begin in the 30s and 40s How estrogen changes during menopause may interact with synapses and microglia Why genetics can influence risk without determining your future The role of diet, movement, mitochondria, hyperbaric oxygen, and social connection About Dr. David Perlmutter Dr. David Perlmutter is a board-certified neurologist and author whose work focuses on brain health, nutrition, metabolic health, and neurodegenerative disorders. His newest book, Brain Defenders, focuses on the brain's immune cells and their relationship to long-term brain health. Resources and People Mentioned Dr. David Perlmutter's official website: https://drperlmutter.com/ Brain Defenders official book website: https://braindefenders.com/ Dr. David Perlmutter on Instagram: https://www.instagram.com/davidperlmutter/?hl=en Connect with Dr. Myers Website: https://www.dramymyers.com/ Inner Circle: https://www.drmyersinnercircle.com Newsletter: https://dramymyers.com/ Facebook: https://www.facebook.com/dramymyers Instagram: https://www.instagram.com/dramymyers Connect with Dr. David Perlmutter Website: https://drperlmutter.com/ Instagram: https://www.instagram.com/davidperlmutter/?hl=en

Marking 350 episodes, Dr. Scott Watier breaks down seven research-backed physiological changes that happen in the body at just 5-10% weight loss, arguing that the "magic" everyone chases at their big goal weight is actually front-loaded far earlier than most people realize. Pulling from journals like Cell Metabolism, Gastroenterology, and Diabetes Care, he walks through the data: a 5% drop in body weight is tied to a 16% reduction in visceral fat and a 24% reduction in liver fat with muscle essentially untouched, a 4-5 point drop in blood pressure, a 38% cut in overnight sleep apnea events, and a 3.5x greater likelihood of a meaningful A1C improvement in diabetics. He makes the case that this is a measurement problem, not a discipline problem — people quit chasing a distant "big number" instead of tracking the waist measurement, blood pressure, or A1C changes already happening under the surface — and ties fasting specifically to defending lean muscle mass while compressing the eating window drives these results. The episode closes with concrete action steps: calculate your own 5% and 10% targets, pick one metric to track instead of just the scale, keep your last bite before 6pm per the earlier Dr. Courtney Peterson research, prioritize protein at every meal, and write down three non-scale outcomes to watch for before the scale rewards you! Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Resources and Downloads: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠***NEW RESOURCE!*** GRAB THE INSULIN RESISTANCE BUCKETS SUMMARY GUIDE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SLEEP GUIDE DIRECT DOWNLOAD⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Partner Links: Get your⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ FREE BOX OF LMNT⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ here!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠25% off a Keto-Mojo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ blood glucose and ketone monitor (discount shown at checkout)! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Our Community: Let's continue the conversation. Click the link below to JOIN the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fasting For Life Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them! Article Link:

In this episode of Reclaim Your Rise, Lauren sits down with Kelsey Lynn Stokes and Francesca Spinello, co-founders of Calycanthus Lingerie, a company creating feminine, functional insulin pump holders for women who wear tubed pumps.Kelsey's story with Risely started years before Calycanthus existed. After living with T1D since age 13, she came to Risely at one of her lowest points with diabetes. Through 1:1 coaching, she brought her A1C from 8.1% to 6.3% and began changing her relationship with T1D.Now, she's taking an insecurity she remembers having as a 22-year-old woman starting on an insulin pump and turning it into something that gives other women more choice in how they dress, date, celebrate, and express themselves.Plus, Kelsey takes us behind the scenes of her career in film and television as a script supervisor, and how living with T1D has given her a unique perspective on diabetes representation on screen.WHAT WE COVER:How Kelsey went from an 8.1 A1C and nearly in tears asking for help to a 6.3 and building a company for the T1D communityThe heartbreaking question Kelsey asked the night before getting her first insulin pump at 22How losing a dress on a train in Italy eventually led to a patented product for women with T1DWhy Kelsey once wondered, “Who's going to love me if I have this on?” and the emotional side of wearing an insulin pump while dating and being intimateThe difference between hiding your diabetes and simply not wanting it to be the first thing people seeWhat TV gets painfully wrong about T1D, from someone who works behind the scenesWhy Kelsey says her 13-year-old self would have been “less scared” if she could see her life nowCONNECT WITH KELSEY + CALYCANTHUS:Kelsey Lynn Stokes(founder): @thewanderingdiabeticCalicanthus Lingerie: @calycanthuslingerieShop ProductsWHAT'S NEXT:

Sabrina Allen was diagnosed with Granuloma annulare and struggled to find relief—until she began incorporating Real Bread into her daily diet. As she made the change, she experienced relief from her symptoms and noticed another unexpected transformation in her menstrual cycle, which finally became regular. Her story is a powerful reminder of how nourishing our bodies with Real Bread made from freshly-milled flour can really make a difference. Topics in this episode include: Granuloma annulare, gluten-free, menstrual cycle, migraines, brain fog, vision, A1C, snacking LISTEN NOW

Your primary care provider is doing their best. But there's something they may not be telling you — not because they're hiding it, but because they simply can't know everything.In this episode of Your Health University, Jamie Preston sits down with Scott Middleton — Founder and Chief Disruption Officer of Your Health — to talk about one of the most underutilized parts of the American healthcare system: specialty care. Scott shares real stories from the field that will make you rethink what you expect from your next appointment, including a patient who had been living in a nursing home for years without ever being offered a weight-loss medication that was available to her, and a lawsuit that turned on a single chest x-ray that no one thought to order.What you'll learn in this episode:Why your primary care provider legally cannot keep up with every new medication, treatment, and specialist recommendation — and what to do about itWhat GLP-1 medications are, who qualifies, and why so many eligible patients are never told they existThe standard of care around lung cancer screening for smokers — and why not knowing this can have life-altering consequencesHow to ask for a specialist referral (and what happens if your provider pushes back)Why behavioral health is one of the most under-accessed specialties in America — and how to change that for yourselfWhat "integrated care" actually looks like when it works — and what you deserve to expect from your healthcare teamYou are the CEO of your own health. This episode gives you tools to act like it. www.YourHealth.Org

In this episode, Ray Cochrane devotes the whole show to Apple’s fall event, the first under new CEO John Ternus. He starts with the iPhone Duo, Apple’s first foldable iPhone. From there, he covers the Apple Watch Series 12, the new Health Age score, the Apple Watch Ultra 4, and AirPods 5 with noise canceling at $129. – Want to start a podcast? Its easy to get started! Sign-up at Blubrry – Thinking of buying a Starlink? Use my link to support the show. Subscribe to the Newsletter. Email Ray if you want to get in touch! Like and Follow Geek News Central’s Facebook Page. Support my Show Sponsor: Best Godaddy Promo Codes Get 1Password Full Summary Cochrane opens from his father’s studio in Michigan, fresh off a trip to Saugatuck Dunes State Park. Lake Michigan stunned him because it looked like the ocean. He had hoped to spot Wisconsin across the water. However, overcast skies and fog hid the far shore. He also apologizes for the hum in the previous episode, his first video session in the studio. Without headphones on, he took the noise for ordinary background sound. The culprit turned out to be a line-level cable plugged in at one end and loose at the other. After tracing it, he rewired the whole desk so every cable is neat and out of harm’s way. Meanwhile, he is still learning the studio’s TriCaster switcher and working on keeping his eyes on the camera. He invites listeners to send suggestions. Additionally, his grandmother had trouble finding the video version on the site. As a result, a site update is coming that uses the alternate enclosure feature, so listeners can switch between video and audio. Time with his grandmother has been a highlight of the trip. Cochrane reflects on how little time he spent with this side of the family after his father moved to Michigan. Next, he flies home to Oregon after some time in Detroit. As the move comes together, he also wants a better way to get recordings off the TriCaster than a USB drive. Sponsor: GoDaddy Economy hosting $6.99/month, WordPress hosting $12.99/month, domains $11.99. Website builder trial available. Use codes at geeknewscentral.com/godaddy to support the show. iPhone Duo: Apple’s First Foldable Arrives Seven Years After Samsung Instead of a spread of headlines, the whole episode covers Apple’s fall event, much like Chris’s recent D23 episode. The event streamed Wednesday as a pre-recorded film. It was also the first event under CEO John Ternus. He took over from Tim Cook, who became executive chairman, on September 1st. It took Apple seven years to answer Samsung’s first Galaxy Fold. Even so, the price barely moved, since the Duo starts at $1,999. Cochrane admits he hoped for something closer to $1,400. Still, based on the marketing alone, the Duo is the upgrade he is most excited about. The Duo is a book-style foldable that opens along a vertical hinge. Closed, it has a 5.4-inch outer screen and is roughly the size of a passport. Open, it reveals a 7.6-inch display, the largest Apple has put on an iPhone. Both screens share the same proportions, so apps simply scale up to fill the bigger screen. Opened flat, the Duo is just 5.2 millimeters thick, which makes it the thinnest iPhone Apple has built. Closed, it measures 11.3 millimeters and weighs 254 grams. By comparison, Samsung’s Galaxy Z Fold8 is lighter and thinner at 201 grams and 4.5 millimeters open. The Crease, the Hinge and the Return of Touch ID The crease was Cochrane’s biggest worry, since it is the most common complaint about folding phones. Apple layers the inner screen with a flexible plastic cover, thin glass, and a titanium plate underneath. Custom adhesives let those layers slide as the phone bends. On top, a microscopically etched matte finish scatters reflections to hide the crease. However, Apple only claims the crease is harder to see, not gone. Early hands-on reports split down the middle. Chance Miller at 9to5Mac found it “hard to notice a crease at most angles.” In contrast, Andrew Romero at 9to5Google, working from early videos, said it looks “just as visible” as on Samsung’s Fold8. The hinge uses more than a hundred parts and a row of magnets to hold the phone shut. Cochrane says it snaps open cleanly, which a $2,000 phone should. Notably, the Duo carries an IP68 rating, surviving six meters of water for up to 30 minutes. That matters on a foldable, because dust in the hinge is a classic way these phones die. The Duo also has no Face ID. Instead, a Touch ID fingerprint reader sits in the side button and works open or closed. Cochrane offers his own theory for the switch. With AI now able to generate convincing faces and video, a fingerprint may simply be the safer biometric. Inside the Duo: Chip, Cameras, Software and Battery The Duo runs the A20 Pro, the same chip as the iPhone 18 Pro, built on a two-nanometer process. A vapor chamber carries heat away so the phone can hold full speed longer. Cochrane welcomes that, since his own phone runs hot while charging or running demanding apps. Two 48-megapixel cameras sit on the back, a main and an ultra-wide. The outer screen unlocks the new tricks. For example, you can shoot selfies with the rear cameras, and Duo Preview lets your subjects see the shot. Smart Take snaps the photo when everyone is posing, and Kid Cue plays Peanuts animations to get kids to look at the camera. On the software side, the Duo ships with iOS 27.1. The Dynamic Island now runs vertically along the side, and Split View puts two apps side by side for the first time on an iPhone. Netflix, Zoom and Slack already support it. The Duo carries two batteries, one in each half, and Apple rates it for up to 24 hours of typical use. Charging to 50 percent takes about 20 minutes with a 60-watt adapter. However, that adapter is sold separately, which Cochrane calls out as a raw deal for first-time buyers. MagSafe and Qi2 wireless charging run at up to 25 watts. Storage starts at 256GB for $1,999 and climbs to $3,199 for 2TB. Preorders open October 16th, and the Duo reaches stores October 23rd. Ternus called it “the most transformational change to iPhone since the original.” Cochrane still wants one, though the price gives him pause, and he asks listeners whether they plan to buy. Apple Watch Series 12 Checks Your Heart Every Five Seconds Next, Cochrane turns to the Apple Watch Series 12 and its new Health Sensing System. The watch reads your pulse by shining green light into your skin and measuring what bounces back. After wrestling with the technical term, photoplethysmography, he notes that everyone sensibly calls it the optical sensor. Apple made those lights bigger and more efficient. As a result, the watch now checks your heart rate every five seconds, all day. It also measures heart rate variability, the tiny wobble between beats, as often as every five minutes. A bigger wobble generally means your body is rested and recovered. Cochrane loved Apple’s swimming ad, where a swimmer finishes his swim and checks his heart rate. To him, it feels far more futuristic than the rugged adventure watches of twenty years ago. Swim tracking itself isn’t new. What changed is the constant background check and a live heart rate readout on the watch face. All of that feeds a new daily readiness score from zero to ten. It weighs your recent activity, training load, vitals and sleep, then updates through the day. Engadget points out that competitors already offer readiness scores and faster sampling. In Cochrane’s view, Apple is catching up to the market, but doing it in a big way. Apple’s Heart Rate Accuracy Study Apple claims no wearable reads heart rate more accurately, and this time it published the study. Testers wore a Series 12 on one wrist and a rival on the other, with a Polar H10 chest strap as the reference. The rivals came from Garmin, Google, Huawei, Samsung, WHOOP and Oura. Across 1,254 people at five sites, Apple led in 139 of 159 comparisons. Eighteen were too close to call. The only two losses went to Google’s Pixel Watch 4 at rest, by less than half a beat per minute. Cochrane appreciated that a fifth of participants had the darkest skin tones, where optical sensors have historically struggled. The Series 12 comes in 42- and 46-millimeter sizes, including a new ceramic version. Battery life holds at 24 hours, and fifteen minutes of charging now buys up to twelve hours. Pricing starts at $399 for aluminum, $699 for titanium and $899 for ceramic. It reaches stores September 18th. Health Age and Apple’s Rebuilt Health App Cochrane admits he first misread this feature, and he is glad his initial read turned out wrong. Apple is rebuilding the Health app around Apple Intelligence, its umbrella name for its AI features. The app adds an Insights tab, a For You section, and a Longevity tab covering seven areas of health. Sumbul Desai, a physician who runs health and fitness at Apple, framed the goal. She said pairing the watch’s sensors with Apple Intelligence lets Apple “translate complex biometric data into clear guidance for users.” In other words, nobody wants to scroll through a spreadsheet of their own heartbeats. Inside the Longevity tab sits Health Age. It weighs your VO2 max, resting heart rate, sleep, and heart rate variability against your real age. You can also add lab results like A1c and LDL cholesterol. Apple’s sample screen shows a body running 3.9 years younger than its birthday. Cochrane finds the feature interesting, and he hopes the data stays private, much like health records at a hospital. However, Apple didn’t share the math behind Health Age. He would like Apple to publish its formula, because people will take a number like that seriously. The new app also adds at-home movement evaluations using the iPhone camera and the watch. Users can book a $119 blood panel covering more than 50 biomarkers at roughly 2,000 Quest Diagnostics locations. Cycle Tracking gains perimenopause and menopause support. The redesigned app arrives later this year, while watchOS 27 lands September 14th. Finally, Cochrane raises a concern about all this monitoring. He hopes Apple built strong safeguards around the health data, because a leak of data like this would bring serious lawsuits. Apple Watch Ultra 4 Can Outlast a 100-Mile Race The Apple Watch Ultra 4 shares nearly everything with the Series 12, from the sensors to the S11 chip. This year, what sets it apart is stamina. Normal use now reaches 50 hours, up from 42, and Low Power Mode stretches to 84. Meanwhile, fifteen minutes on the charger buys up to 18 hours, where last year’s model managed 12. A new Max Extended Workout mode tracks up to 45 hours of running or hiking, with GPS logging every second. Apple says that is typically enough to finish a 100-mile race. The watch also uses dual-frequency GPS, which listens to two satellite signals to reject readings bounced off tall buildings. DC Rainmaker came away impressed with both watches. As Ray Maker put it, “I’d argue they’re the biggest leaps in Apple Watch hardware and features since they launched the Ultra series back a few years ago.” The Ultra 4 holds at $799 and ships September 18th. Audio Intelligence and the Always-Listening Question Both new watches also gain a set of listening features Apple calls Audio Intelligence. Sound Recognition alerts deaf or hard-of-hearing users to sirens, alarms, doorbells, or a crying baby. Shazam names nearby songs without being asked. Then come the two raising eyebrows: Live Rewind and Siri Recap. Live Rewind shows the last fifteen seconds of your conversation as text with a double press of the Digital Crown. Siri Recap hands you a title and key points after a conversation, leaving out financial details and ID numbers. Both arrive in beta later this year, in English first, and need an iPhone 16 or newer. Cochrane saw the pushback coming. To replay fifteen seconds, the watch has to be listening before you ask. Apple answers with privacy promises, including that everything is opt-in and raw audio is deleted after processing on the chip. Still, he argues that opting in means choosing to give up privacy, and he has a hard time believing the processing stays on the device. AirPods 5 Bring Noise Canceling to $129 AirPods 5 comes in two versions, and the headline is price. Until now, noise cancellation in the regular AirPods cost $179. Both AirPods 5 models include it, starting at $129. Noise canceling is harder in the regular AirPods, because they lack the rubber tips that seal your ear. Apple’s AirPods marketing director Eric Treski admitted as much in 2024, calling it “really, really hard to create this great ANC quality in a non-ear-tip product.” Nevertheless, Apple says AirPods 5 removes up to 50 percent more outside noise than AirPods 4 with noise canceling. Interestingly, the chip and microphones are unchanged. The gain comes from reworked vents and ports in the shell, plus smarter software. For perspective, Apple says AirPods Pro 3 still cancel up to three times more noise. Gizmodo found AirPods 5 “did a good job silencing the background noise, but not entirely.” The $129 model charges over USB-C. For $149, you add a wireless charging case, a Find My speaker, a volume swipe on the stem, and an extra hour of listening. Both models also carry an IP57 rating and support Live Translation. They reach stores September 18th. How Apple Filmed the Event Cochrane closes by praising the production itself. Apple built different scenes and backgrounds throughout the film, and Six Colors noted a Hollywood backlot segment with a fake rainstorm, Roman soldiers, and astronauts. The closing card read “Shot on iPhone. Edited on Mac.” He still hopes to get an iPhone Duo, though he isn’t sure about paying two grand. For now, he may stick with his current phone. Cochrane wraps up by pointing listeners to the GNC Insider program, the newsletter, and podcastapps.com, adding that he likes Pocket Casts. Listeners can reach Ray or Chris at geeknews@gmail.com. He flies back to Oregon next, with another audio episode planned for Monday and a video site update coming this week. The post Apple’s September Event: iPhone Duo, Apple Watch Series 12, and AirPods 5 #1877 appeared first on Geek News Central.

Episode SummaryHbA1c turns up on almost every routine blood panel, and in this Monday mini episode Mikki looks at how much it can genuinely tell you. She starts with the physiology — haemoglobin picks up glucose non-enzymatically, red cells live 100 to 120 days, and the result is a weighted average of glucose exposure that leans heavily on the most recent month. That matters more than it first appears, because anything that shortens or lengthens red cell lifespan moves the number without blood glucose changing at all. Iron deficiency, heavy menstrual bleeding, foot strike haemolysis in runners, thalassaemia and sickle trait, recent blood donation and B12 deficiency can each push a result in one direction or the other.From there Mikki works through the research-based critiques: insulin resistance and beta cell decline can precede an abnormal HbA1c by many years, the test is highly specific but only about 50 per cent sensitive against an oral glucose tolerance test, an average conceals the shape of the glucose curve, and both genetics and ordinary measurement noise move the number independently of glucose. She closes on the practical side — where HbA1c does earn its place, why she still thinks a result of 40 or 41 deserves a conversation with your doctor, and which markers are worth reading alongside it.Key TopicsWhat HbA1c actually measures. Glycation is non-enzymatic with no regulatory brake, so it proceeds in proportion to how much glucose is around and how long the cell is exposed. A red cell cannot repair it, making it a passive record of the preceding 8 to 12 weeks.The "three-month average" is weighted, not even. About 50 per cent of the movement toward a new value happens in the first month, which is why a result can shift over six weeks.Falsely low results. Haemolysis of any cause, haemoglobinopathies such as sickle trait and thalassaemia trait, ongoing blood loss, blood donation, recent transfusion, advanced liver disease, and starting iron treatment in someone iron deficient.Falsely high results. Untreated iron deficiency anaemia, B12 and folate deficiency, splenectomy or functional asplenia, and aplastic anaemia.Athletes get it from both directions. Foot strike haemolysis lowers A1c relative to true glucose exposure, while the iron deficiency common in female athletes raises it — and the two distortions can partly cancel out, so the number alone will not tell you which is happening.Correcting iron can drop A1c without any dietary change. Mikki's worked example is a woman going from 42 to 37 mmol/mol once her iron is sorted, and her concern is that the change gets credited to a nutrition intervention she never needed.The cut-offs, in New Zealand and US units. Roughly 30 to 39 mmol/mol normal, 41 mmol/mol pre-diabetes and 50 mmol/mol diabetes locally, against WHO and ADA thresholds of 42 and 48 mmol/mol. Type 2 diabetes throughout, not type 1.HbA1c is a lagging signal. Insulin markers can diverge from controls up to 20 years before diagnosis, and beta cell function is already down around 50 per cent by the time someone meets diagnostic criteria — so a normal HbA1c is compatible with a long stretch of compensated insulin resistance.Specific but not sensitive. Against an oral glucose tolerance test, sensitivity of about 50 per cent with specificity around 97 per cent, and screening work in which the HbA1c criteria missed a large majority of pre-diabetes.What to read alongside it. Fasting glucose, ideally fasting insulin, waist-to-height ratio, triglyceride-to-HDL ratio and a fasted lipid panel — plus your own historic trend rather than the population cut-off.Chapters00:00 How HbA1c works and what distorts it03:41 Athletes, foot strike haemolysis and iron06:23 New Zealand and US cut-offs08:40 Why HbA1c lags insulin resistance12:12 Averages, genetics and measurement noise15:41 Your own trend, and ethnic differences18:41 Where HbA1c earns its place21:31 Sign-off and new recipesGuest / ResourcesSolo episode — no guest.Referenced in the episodeWorld Health Organization — pre-diabetes around 42 mmol/mol (6%), diabetes at 48 mmol/mol (6.5%)American Diabetes Association — diabetes at 48 mmol/mol (6.5%)Mikki discusses findings from a number of published studies through the episode. They are described in the audio rather than cited by name, so no reference list is given here.Tests and markers discussedHbA1c · fasting glucose · fasting insulin · oral glucose tolerance test · continuous glucose monitor · HOMA2-IR · HOMA2-B · ferritin · fasted lipid panel · triglyceride-to-HDL ratio · waist-to-height ratioFind MikkiInstagram, Threads and X — Mikki WillidenFacebook — Mikki Williden NutritionWebsite — mikkiwilliden.com — one-on-one calls and the recipe portal Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwillidenNZ listeners - save 10% off Calocurb by using the code Mikkipedia10 at www.calocurb.co.nzSave 20% on all Nuzest Products WORLDWIDE with the code MIKKI at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz supplement: MIKKI saves you 25% at www.curranz.co.nz or www.curranz.co.uk off your first order

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about Retatrutide, the third-generation injectable making waves as the most powerful weight-loss drug studied yet. It targets three hormone pathways at once instead of just one or two, and early trial participants have lost staggering amounts of weight, some over 30 percent of their body weight. But is more always better? Jenn breaks down how this triple mechanism works in the body, what the research shows so far, and why it might finally help the roughly 10 percent of people who never responded to earlier GLP-1s. Still, she has been raising the same concerns since Ozempic first came onto the scene, and this new drug is no exception. Is Retatrutide the breakthrough the weight loss world has been waiting for, or just a stronger version of the same unanswered questions? Tune in to hear Jenn's full take. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/ RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramOzempicAmerican Diabetes Association Retatrutide—A Game Changer in Obesity Pharmacotherapy - PMCGlucagon | HormonesInternational Journal of Molecular SciencesHyperglycemia vs. Hypoglycemia: Differences in Causes and Symptoms - GoodRxGlucagon Control on Food Intake and Energy Balance - PMCLilly Phase 3 StudyComparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials - ScienceDirectLilly - RetatrutideWhat Is Osteoarthritis? Causes, Symptoms, and Treatments - GoodRxPotential Retatrutide Benefits You Should Know About - GoodRxClinical TrialsStudy Details | NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) | ClinicalTrials.govClinical TrialsStudy Details | NCT06383390 | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)ClinicalTrials.govClinical TrialsNCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain | ClinicalTrials.gov11 GLP-1 Side Effects You Should Know About - GoodRxTriple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine Counterfeit DrugsPeptides for Weight Loss: What They Are and How They Work - GoodRxJenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Retatrutide, Glp 1, Gip, Glucagon, Weight Loss, Ozempic, Wegovy, Mounjaro, Zepbound, Tirzepatide, Semaglutide, Insulin Sensitivity, Gastric Emptying, Appetite Suppression, Blood Sugar Control, A1c, Glycated Hemoglobin, Liver Steatosis, Fatty Liver Disease, Diabetic Kidney Disease, Type 2 Diabetes, Metabolic Dysfunction, Cardiovascular Risk, Osteoarthritis, Bone Density, Muscle Loss, Body Composition, Clinical Trials, Phase Three Trials, Injectable Medication, Weight Loss Drug, Pharmaceutical Intervention, Hunger Hormone, Satiety, Nausea, Constipation, Gastrointestinal Side Effects, Compounding Pharmacy, Counterfeit Medication, Obesity Treatment, Incretin Hormone, Retatrutide Weight Loss Results, Third Generation Glp 1 Medication

LEXINGTON, Ky. (September 10, 2026) – Taking steps toward better health doesn't always have to begin in a doctor's office. Sometimes it can start with a blood pressure check, a conversation about nutrition or a simple screening that identifies a potential health concern before it becomes something more serious. On Saturday, Sept. 19, UK HealthCare and University of Kentucky Cooperative Extension will bring those opportunities — along with plenty of family-friendly activities — together for the fourth annual Be Healthy Bash. The free community health and wellness event will take place from 11 a.m. to 3 p.m. at the Fayette County Extension Office, located off Red Mile Road. More than 50 organizations from across UK, along with community partners and sponsors, will provide health screenings, wellness information and other resources designed to help Kentuckians take steps toward healthier lives. Trudi Matthews, chief of Value-Based Programs, Public Policy and Community Initiatives for UK HealthCare, says events like the Be Healthy Bash are an important part of the university's efforts to reach people before health concerns become more serious. "We are trying to do the right thing to not only care for the people who are in our clinics and our hospitals and other facilities, but we're also working really hard to try and go further upstream to prevent downstream complications," Matthews said. Visitors to the Be Healthy Bash can access services and information including blood pressure checks, vision screenings, hemoglobin A1C testing, immunizations and resources related to heart disease, diabetes, obesity, cancer, behavioral health and other health concerns. UK Cooperative Extension and other university experts will also offer resources focused on nutrition and healthy eating, including cooking demonstrations and information designed to help families prepare healthier meals that are affordable and accessible. But Matthews emphasizes that the event is intended to be more than a traditional health fair. Activities include Zumba, inflatables, a petting zoo, a farmers market, a smoothie bike and other opportunities aimed at making health and wellness approachable — and fun — for people of all ages. The event is free, and lunch will be provided to the first 500 attendees. Organizers expect between 500 and 1,000 people to attend this year. On this episode of "Behind the Blue," Matthews discusses the importance of preventive care, the barriers that can make accessing health resources difficult and how the Be Healthy Bash brings expertise from across UK and UK HealthCare together in one place to help Kentuckians connect with screenings, information and follow-up care. 'Behind the Blue' is available via a variety of podcast providers, including Apple Podcasts, YouTube and Spotify. Subscribe to receive new episodes each week, featuring UK's latest medical breakthroughs, research, artists, writers and the most important news impacting the university. 'Behind the Blue' is a production of the University of Kentucky. Transcripts for most episodes are now embedded in the audio file and can be accessed in many podcast apps during playback. Transcripts for older episodes remain available on the show's blog page.  To discover how the University of Kentucky is advancing our Commonwealth, click here. This interview has been edited for time and clarity.

How many times have you been told you'd never get better? That this is just the way things are now - your knee, your back, your body, your health - and you should learn to live with it? What if the doctors, the X-rays, and the diagnoses were never the whole story, and what if your body has been ready and waiting to heal this entire time, just waiting for permission? Michael shares his own remarkable story - six knee operations by age ten, being told he'd never run again, getting hit by a car while racing bicycles in Europe, years of chronic back pain doctors chalked up to permanent damage - and how he ultimately ran up Vermont's largest mountain and completed a full Iron Man, pain-free. From there, he walks through the real reason so many bodies stay stuck even when they're fully capable of healing, and leads a live group healing session designed to help you feel safe enough to finally let your own healing begin. This isn't about pushing, forcing, or gritting your way back to health. This is about understanding that no healing has ever happened from a place of fight-or-flight, and that the very first step, always, is simply letting your body know that it's safe. Key Topics: Michael's own healing journey: from being told at age 11 he'd never walk properly, let alone run, to running straight up a 4,000-foot mountain and completing an Iron Man triathlon. Why healing doesn't begin in the mind or the body, but in the heart, and why permitting yourself to feel scared, angry, or doubtful is the necessary first step, not something to bypass. The "ego of the body" concept: why your nervous system defaults to the known, even painful, status quo, because change itself registers as dangerous. Why nothing heals from a state of cortisol and fight-or-flight, and why a body that finally feels safe often wants deep rest first, before real healing can begin. Two live attunements for anchoring into safety: starting in third person ("You are safe, you're okay, you can heal") before shifting into first person ("I am safe, I am safe, I am safe") to gently bypass nervous system resistance. Real results shared from this summer's Come Back to Life program, including declining A1C and AFib numbers, a straightened curved spine, a participant coming off an oxygen tank, and significantly reduced phantom limb pain. The power of the "imaginary state": seeing yourself already healed, already whole, already living the life you want, because intention, not current reality, is what actually drives transformation. Michael's own PTSD story from being hit by a car in France, and why reliving a trauma over and over is often the nervous system's way of searching for the safety it never got to feel the first time. Your body came here whole. It carries the resonant frequency to return to perfect health; it's simply been waiting for you to decide, and to feel, deep in your heart, that it's safe to try. Healing was never about forcing your way up the mountain. It's about approaching yourself with so much love, kindness, and compassion that your body finally, gently, believes it's allowed to come back to life.

Normal blood sugar doesn't always mean everything is metabolically normal. Episode #274

Jasmine Jones was five months into treatment for an aggressive form of breast cancer when she ended up in the ICU with DKA and heard another life-changing diagnosis: Type 1 diabetes.As a CrossFit athlete, coach, and military veteran who had always built so much of her identity around health and strength, Jasmine suddenly found herself learning how to manage insulin while she was still going through chemotherapy.In this episode, Jasmine sits down with Lauren to talk about navigating two life-changing diagnoses in less than a year, from being discharged from the hospital scared to give herself insulin and seeing blood sugars in the 300s, to eventually going from 52% time in range to consistently reaching 85–90%. She also opens up about rebuilding her relationship to food, , her identity, and how she went  from thinking, “This can't be life,” to feeling like she was back in the driver's seat.This is one of our favorite conversations of the year. Enjoy.WHAT WE COVER:How Jasmine was diagnosed with Type 1 diabetes just five months after her breast cancer diagnosis, while still undergoing chemotherapy and immunotherapyWhat it was like to leave the ICU with a new T1D diagnosis, a sliding scale, and very little understanding of how to actually manage insulinHow Jasmine went from an 8.4 A1C and 52% time in range to 85% consistently, all while still recovering from cancerThe exact mindset shift that took Jasmine from terrified to give herself insulin to confidently adjusting her own settingsWhat she did to rebuild her confidence with food after a diagnosis sent her relationship with food into a tailspinWhy this lifelong athlete had to completely rethink what “strength” meant after cancer and T1D changed what her body could doWhy Jasmine believes finding people who understand T1D changed the trajectory of her first year with diabetesWHAT'S NEXT:

For years, people with diabetes have heard the same message: get your A1C as low as possible. Tighter blood sugar control is always better… right?Not necessarily.For many older adults, especially those living with multiple health conditions, frailty, cognitive changes, or functional limitations, aggressively lowering blood sugar can increase the risk of hypoglycemia. And in older adults, low blood sugar can have serious consequences, including confusion, weakness, dizziness, falls, hospitalization, and loss of independence.In this episode, we're talking about why diabetes management changes as we age and why there is no single “perfect” A1C target for everyone.In this episode, you'll learn:• Why the traditional “lower is always better” approach doesn't apply to every older adult• Why current diabetes guidelines recommend individualized blood sugar and A1C targets• Why hypoglycemia can be particularly dangerous and harder to recognize in older adults• Common symptoms of low blood sugar that may look different with age• How low blood sugar can increase the risk of falls and other serious complications• Why a moderately higher A1C may actually be the safer choice for some older adults• Which older adults may benefit from more relaxed blood sugar targets• What questions to ask your healthcare provider about your personal diabetes goalsThe big takeaway? Good diabetes care isn't about chasing the lowest possible number. It's about finding the safest and most appropriate target for the individual sitting in front of you.If you're an older adult with diabetes or care for someone who is, this is a conversation worth having with your healthcare team.More ResourcesLooking for more practical, evidence-informed nutrition information for older adults?Visit my website: https://longtermcarerd.com/You'll find articles, resources, and practical nutrition information focused on older adults and the healthcare professionals who care for them.Are you a dietitian or healthcare professional working with older adults? Explore additional clinical resources, education, tools, and support through Clinical Nutrition Central:https://clinicalnutritioncentral.com/Medical DisclaimerThis podcast is provided for educational and informational purposes only and is not intended to provide individual medical advice, diagnosis, or treatment. The information discussed should not replace advice from your physician, dietitian, pharmacist, or other qualified healthcare professional.

Dr. Sarai Ambert-Pompey opened Libélula Primary Care in Boise, Idaho. "Libélula" is Spanish for dragonfly, chosen for transformation. One year in, she joins Dr. Maryal Concepcion to talk about what changed when she left the VA for Direct Primary Care.Her path is unconventional: CompUSA and GameStop, Sony PlayStation reviewer training, oncology research at OHSU, then internal medicine residency in Boise. At the VA she joined a Primary Care Center of Excellence and helped launch the Boise Clinical Resource Hub, delivering clinic-to-clinic telehealth to rural sites across the Northwest, then trained physicians in telemedicine through the Ada County Medical Society during the pandemic.In this episode:Why time is the intervention - patients arrive never having been told their A1C goal, their blood pressure goal, or what their medications are for. Longer visits keep high ER utilizers out of the ER.Culturally responsive care in Idaho - Boise is predominantly white, but farming communities and employers like Micron bring diversity the traditional system was never built to serve. Healthcare trauma can take several visits to overcome before a patient consents to a blood draw.Telehealth done right - her top three: screen whether the visit is appropriate, build an emergency protocol and know your state's consent law, and actually perform a physical exam on video. Most clinicians skip that last one.How to vet an EHR - test customer service response time first, ask about interoperability, run a full patient walkthrough instead of the salesperson's highlight reel, get pricing broken out line by line, ask how an AI scribe stores data, and watch for 12-month contracts.Community as marketing - she launched a Walk with a Doc chapter before the clinic opened. Chamber involvement, immigration medical exams, and one paid social promo that returned its investment in a week.Leaving the system - 15 pounds lost, sleep restored, weekends back. "I tell anyone who will listen: I wish I had done it earlier."Mentioned: IN -PERSON DPC SUMMIT COMING IN OCT 2026! Illinois DPC Summit, first week of October, open to out-of-state physicians - register at caradirectcare.com/summit · Walk with a Doc · Latino Conservation Week · Idaho Hispanic Chamber of CommerceFree DPC startup checklist, the Physician Owner's Planner, and the DPC Toolkit Magazine: mydpcstory.com Leave a voice message for the show: mydpcstory.com/contact Follow @mydpcstory · Leave a 5-star review on Apple PodcastsCONGRATULATIONS Dr. Oropeza!!!! Learn more about Oropeza Family Health at https://oropezahealth.com/ Get your copy of the Physician Owner's Planner today at mydpcstory.com/library Learn more about Hint Summit at: https://go.hint.com/45zknvf Support the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOADBecome A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

In this episode, Pearl shares a very personal tale about her blood sugar and the unexpected turn it took as she entered menopause. For years, her numbers looked great while living the Trim Healthy Mama lifestyle. But as time went on, something began to change. Even though she was still eating well and doing what had always worked for her, her A1C kept moving in the wrong direction. A doctor gave her two pieces of advice. One she took. The other sent her down a completely different path. We're talking about blood sugar, muscle, protein, carbohydrates, aging, and why sometimes the answer isn't simply eating less or cutting out another food group. Pearl also shares what this journey taught her about strength training, starting imperfectly, and refusing to let intimidation keep you from building a healthier future. If you've ever wondered why your body seems to respond differently as you get older or felt like you're doing everything “right” and still not seeing the results you expect this is one you'll want to hear. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more... Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more.. that's coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Welcome to September! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved – more on that coming up. But please register – the link is in the show notes. So much going on over here – tomorrow night we have our Club 1921 in Charlotte, later this month Moms' Night Out Detroit/Bloomfield and in October we're going to Seattle. Please join us. More at d-c dot com slash events. Okay.. our top story this week: XX Another indication for Mounjaro – the FDA approved it to lower the risk of major adverse cardiovascular (CV) events (MACE), including CV death, non-fatal heart attack, or non-fatal stroke in adults with type 2 diabetes who are at high risk for these events. Mounjaro – the brand name of tirzepatide - is already approved as an adjunct to diet and exercise to improve blood sugar in adults and children 10 years of age and older with type 2 diabetes. The approval was based on results from the largest and longest tirzepatide study to date, enrolling more than 13,000 participants across 30 countries over more than four and a half years. In the trial, Mounjaro demonstrated non-inferiority to Trulicity (dulaglutide), a GLP-1 treatment with established cardiovascular benefit, with an 8% lower rate of cardiovascular death, heart attack or stroke (MACE-3). The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI: 0.83, 1.01) for Mounjaro compared to Trulicity (dulaglutide). https://www.prnewswire.com/news-releases/fda-approves-lillys-mounjaro-tirzepatide-to-reduce-cardiovascular-risk-in-adults-with-type-2-diabetes-302862415.html XX The FDA approves the Libre Duo – the first device designed to continuously monitor both blood sugar levels and ketone levels in people with diabetes. The Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System is now approved for those ages 2 and older. Until now, the agency said, people had to monitor ketone levels with separate tests that only provided a single measurement at one point in time. The new system combines blood sugar and ketone tests and monitors them continuously. Readings -- and alerts in case of dangerous trends -- are sent wirelessly to a smartphone app. The FDA previously granted "breakthrough device" status to the system, which is meant to expedite the device's development and review. https://www.upi.com/Top_News/US/2026/08/25/fda-oks-blood-sugar-ketone-monitor/5521787688375/ XX Diabetes tech firms Dexcom and Abbott are watching closely for a Medicare coverage expansion that could significantly broaden access to their glucose sensors. The Centers for Medicare and Medicaid Services is expected to expand Medicare coverage of continuous glucose monitors to people with diabetes who do not take insulin. Currently, coverage is limited to people with Type 1 or Type 2 diabetes who take insulin or have a history of problematic low blood sugar. Dexcom CEO Jake Leach told investors in a late July earnings call that the company expects to hear back from the CMS before the end of the year, with coverage going into effect in mid-2027.     Dexcom presented results of a randomized, controlled trial earlier this summer at the American Diabetes Association's Scientific Sessions that it expects will support the CMS' decision. The 26-week study found that people who used a CGM had a larger hemoglobin A1C reduction than the control group and spent five more hours per day in a normal glucose range than the control group. https://www.medtechdive.com/news/dexcom-abbott-await-medicare-coverage-expansion-for-cgms/828775/ XX A new study suggests continuous glucose monitors (CGMs) may offer benefits for people with type 1 diabetes that go beyond improving blood sugar and reducing hypoglycemia.   Researchers analyzed health records from more than 8,400 adults with type 1 diabetes receiving care through the Veterans Health Administration. Over one to four years of follow-up, people who started using a CGM had a 10% to 16% lower risk of death from any cause compared with those who did not use one.   The association appeared strongest among people over age 65 and those who were not using insulin pumps. Researchers did not find meaningful differences based on A1C, race or ethnicity, or frailty.   Importantly, this was an observational study using medical records, not a randomized clinical trial, so it cannot prove that CGM use directly caused the lower death rate. But the findings suggest CGM may have important long-term health benefits beyond glucose management.https://visualize.jove.com/42319755-continuous-glucose-monitoring-initiation-is-associated-with-reduced-mortality-in-older-onset-type-1-diabetes-patients-a-target-trial-emulation-study-within-the-veterans-health-administration XX We've been talking about people without diabetes using CGMs for a long time.. now a new study weighs in. Research published in JAMA finds that this wellness trend isn't helpful for people without a diabetes diagnosis. They found that the strongest evidence for CGM use is for people who are already living with diabetes, but not for those without the condition who use them for wellness purposes. It's also worth noting, though, that this new study is a narrative review. This means that the researchers drew their conclusions from the findings reported in several other studies. More randomized controlled trials would be necessary to see whether there are any meaningful health benefits of using a CGM if you don't have diabetes.   Dower also warned that constantly monitoring your blood sugar when you don't have diabetes could lead to unintended health anxiety. In some cases, you may even make accidental lifestyle changes that could be harmful. "[Blood sugar] spikes may occur after meals, but if this leads someone to replace healthy food such as fruit with unhealthy food such as something high in fat but low in carbohydrate, the glucose information has done more harm than good," Dower said. https://www.verywellhealth.com/blood-sugar-monitor-for-people-without-diabetes-12058575   XX   Could metformin somehow influence the biological processes that drive aging? A new review found evidence that metformin may affect several key features of aging, including how cells use energy, inflammation, cellular damage and even some changes in gene activity. Animal studies have shown longer lifespans or improvements in markers of biological aging, while some human studies have also found promising results.   But researchers say there's still no proof that metformin actually slows aging or helps healthy people live longer. Most human research has involved people with diabetes or other health conditions, and one large trial found that while metformin helped prevent type 2 diabetes, it did not reduce cancer, cardiovascular disease or deaths.   Researchers say larger clinical trials in people without diabetes are needed to determine whether metformin can truly extend healthy lifespan—or whether its benefits are primarily related to preventing and treating specific diseases. https://www.technologynetworks.com/drug-discovery/news/metformin-may-influence-longevity-through-the-gut-microbiome-and-epigenetic-changes-416035 XX More to come including more research on a spice thought to help diabetes, predictions about the number of people who may be living with type 1 in the years to come around the world, and a connection I didn't know about between diabetes and Dolly Parton.   XX A compound found in turmeric may help protect blood vessels from some of the damage caused by Type 1 diabetes. In rats, curcumin reduced inflammation, improved cellular signaling, and restored vascular health to levels resembling those of nondiabetic animals. The results hint at a possible new way to reduce the long-term cardiovascular risks of diabetes, but human trials are still needed. Curcumin, the natural compound responsible for turmeric's vivid yellow color, is widely studied for its anti-inflammatory and antioxidant properties. https://www.sciencedaily.com/releases/2026/08/260824065543.htm XX New research estimates the number of people living with type 1 diabetes (T1D) worldwide will increase by 29% from 9.4 million in 2025 to 12.1 million in 2049. This will be presented at EASD, the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2 The USA will see an increase of over half a million, going from 1,492,825 to 2,055,235. The authors suggest that the reasons for the predicted high incidence and prevalence in 2049 in countries such as Australia, US, UK are likely to be a combination of genetics, environmental triggers and also high case detection rates (due to the good health care infrastructure here and in other HIC). Unlike previous estimates, the DIAMOND-T1D model takes historical patterns of insulin availability into account and aims to provide global, regional and country-specific estimates of T1D incidence, prevalence and mortality from 1900 to 2050. Although the majority of people with T1D live in high-income countries (HIC) and middle-income countries (MIC), the largest relative increase in the T1D prevalence is expected to occur in LIC as access to insulin, glucose monitoring and survival all improve in those countries. https://www.news-medical.net/news/20260828/Type-1-diabetes-cases-projected-to-increase-worldwide-by-2049.aspx XX Early initiation of statins after a diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study published in The Lancet Regional Health – Europe. According to the Lancet Commission, nearly half of dementia cases could theoretically be prevented by eliminating 14 risk factors. "Detecting and treating high levels of low-density lipoprotein cholesterol (LDL-C) from midlife is one such highlighted risk factor," From Danish registers, researchers identified 132,585 statin-naive individuals who developed type 2 diabetes from 2006 through 2019, with follow-up until the end of 2021.   Medical records were searched for diagnoses of all-cause dementia. A clone-censor-weight design was used to analyze dementia incidence in patients with no statin initiation within five years after diagnosis, in those with early statin initiation within one year and in those with late statin initiation between one and five years after diagnosis.   https://medicalxpress.com/news/2026-08-early-statins-diagnosis-diabetes-dementia.html   XX We are heartbroken over the loss of our friend Dolly Parton. Dolly was a beloved icon whose extraordinary generosity, warmth, and compassion touched countless lives, including those of the Children's Diabetes Foundation and the Barbara Davis Center for Diabetes. Her support of The Carousel Ball and Carousel of Hope Ball reflected her deep commitment to helping children and families affected by type 1 diabetes. Beyond her remarkable talent, Dolly will be remembered for the kindness and joy she shared so generously with others. Our hearts are with her family, friends, and all who loved her as we celebrate her extraordinary life and lasting legacy. She will be deeply missed.    

In this episode of the Rest, Eat, Move Podcast, Matt explores the growing popularity of GLP-1 medications, peptides, hormone replacement therapy, TRT, and other “optimization” technologies through the lens of Limitless. The central message is to “know your numbers” and ask better health questions before reaching for an easy button—including understanding cholesterol/lipids, glucose and A1C, triglyceride-to-HDL ratio, homocysteine, inflammation, thyroid, vitamin D, kidney function, and hormone levels. The episode argues that while medications and emerging therapies can be powerful medical tools, long-term health should also focus on the fundamentals: rest, eat, move, lifestyle, sleep, exercise, nutrition, stress management, and establishing personal health baselines over time.#GLP1#Longevity#HormoneHealth#MetabolicHealth#HealthyAgingontargetliving.com

Independent pharmacy owners Richard Stryker, RPh., (Bayshore Pharmacy) and Theresa Tolle, BPharm, FAPhA,  (Bay Street Pharmacy) join PQS host Rosalyn Otting, PharmD, to break down how performance-based care is reshaping pharmacy revenue. They cover the three keys to getting paid for clinical programs: prioritizing opportunities, fitting them into daily workflow, and scaling them for growth. Topics include MedSync as the anchor for clinical billing, quarterly check-ins and on-time-fill bonuses, point-of-care testing (blood pressure, A1c), pay-for-performance networks tied to Medicare Star measures, and staff buy-in strategies for rolling out new programs. The episode closes with a look ahead to 2027 Star Rating changes, including a new depression screening measure, and where pharmacists see the biggest opportunities over the next 3-5 years, from cardiovascular screenings to maternal health and community-based care.

Neurologist David Perlmutter MD says the beta-amyloid theory of Alzheimer's is wrong — and the real culprit is your brain's own immune cells. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with the #1 New York Times bestselling author to unpack his new book Brain Defenders: how diet, blood sugar, and metabolic health flip the brain's microglia from protective to destructive, why anti-amyloid drugs offer "trivial" benefit, and which biomarkers actually predict your brain's future.Chapters:00:00 — Introduction01:38 — Why He Left Mainstream Neurology to Prevent Brain Decline05:24 — Building the World's Largest Integrative Neurology Practice06:55 — The Common Pathway From Metabolism to Brain Degeneration08:25 — Why the Beta-Amyloid Theory of Alzheimer's Is Wrong09:11 — What Are Microglia? The Brain's Immune Cells (M1 vs M2)12:13 — From Brain "Glue" to Master Regulators of Your Synapses16:00 — How Body Inflammation and Cytokines Reach the Brain18:15 — Leaky Gut, the Microbiome, and Brain Degeneration19:46 — Ultra-Processed Foods Raise Alzheimer's Risk Up to 270%25:02 — Synaptic Pruning: The Link Between Autism, ADHD and Alzheimer's29:36 — Why Diabetics Recover Worse From Head Trauma31:51 — Anti-Amyloid Drugs: "Trivial" Benefit, Serious Harm35:37 — The Biomarkers to Track: Fasting Glucose, Insulin, A1C40:09 — On the Horizon: Mitochondrial Therapies and Microglial Transplants45:26 — Glyphosate, Air Pollution and 40Hz Light Therapy47:00 — Brain Defenders Releases August 18 — Final TakeawaysKey takeaways:Alzheimer's is increasingly understood as a "synaptopathy" — a disease of lost synapses driven by the brain's own immune cells (microglia), not simply beta-amyloid plaque.Microglia shift from supportive (M2) to destructive (M1) in response to metabolic signals: high blood sugar, insulin resistance, elevated blood pressure, excess body fat, and inflammation.A long-term cohort found each daily serving of ultra-processed food raised Alzheimer's risk ~13%, with 10+ servings/day linked to a 2.7-fold (270%) increase.A Cochrane review of anti-amyloid antibodies found "trivial" cognitive benefit alongside meaningful harm, including brain swelling and microbleeds (ARIA).The most actionable brain biomarkers are cheap and accessible: fasting glucose, fasting insulin, A1c, waist circumference, and a continuous glucose monitor — aim for optimal, not just "normal."Emerging frontiers target the mitochondria inside microglia — metformin, CoQ10, urolithin A, exercise, fasting, ketones, and 40Hz gamma light therapy.Studies & sources:Weinstein et al., J Prev Alzheimers Dis — ultra-processed food and Alzheimer's riskCochrane Review (2026) — anti-amyloid monoclonal antibodies for Alzheimer'sIaccarino, Tsai et al. (Tsai Lab, MIT) — 40Hz gamma light and microgliaDr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Oliver is an engineer who spent fifteen years being told his A1c was fine. Then he pointed an AI model at his own loop data and found out what his settings had really been doing. twiist - A different type of insulin pump has arrived ABLEnow save for today's needs or invest for tomorrow Eversense CGM MiniMed Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Dr. Mohammad Ashori is a board-certified family medicine physician, health coach, and rock climber. We talked about the importance of putting on muscle, how much rest we need between training sessions, nutrition and metabolic health, zone 2 cardio, key metrics and blood markers to track, different levels of data, why some data can be misleading or harmful, relative vs. absolute risk, and much more. Want to work with Dr. Ashori? Get 15% off your 1st health assessment with Dr. Ashori. Book your schedule here and use the code: NUGGET15 Want climbing or nutrition coaching? Free Masterclass (Learn more about Climb Accelerator)

The FDA just expanded Mounjaro's label to include reducing the risk of major adverse cardiovascular events, and the headline is easy to love and easy to misunderstand. We slow it down and translate what the approval actually means for people living with type 2 diabetes, especially those worried about heart attack, stroke, and cardiovascular death.We unpack the exact endpoint behind the claim: MACE, which combines cardiovascular death, non-fatal heart attack, and non-fatal stroke, and we clarify what it is not saying (no, it is not “erasing plaque” or curing atherosclerotic cardiovascular disease). We also explain the real-world nuance around branding and indications: Mounjaro and Zepbound are both tirzepatide, but FDA labels are population-specific, and that can affect clinical decisions and insurance coverage.Then we walk through the Surpass-CVOT cardiovascular outcomes trial in plain English. The key twist is the comparator: tirzepatide was tested against Trulicity (dulaglutide), an active GLP-1 medication with known heart benefit, not placebo. That's why understanding noninferiority vs superiority matters so much. We talk hazard ratios, absolute vs relative risk, and the surprising finding that bigger weight loss and a larger A1C drop did not translate into statistically superior cardiovascular outcomes during the study window.We close with practical guidance and a list of questions you can bring to your own checkup, including whether you have established cardiovascular disease, what makes you “high risk,” whether other cardioprotective meds are already doing the job, how dose changes could affect insulin or blood pressure meds, and what it will actually cost. If you found this helpful, subscribe, share the show with someone managing diabetes risk, and leave us a review so more people can find clear medical context.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

Forget the scale - it doesn't tell you what actually predicts longevity. In this episode, Dr. Barrett walks through a 5-part scorecard you can start tracking from home: waist-to-height ratio, grip strength, metabolic markers (glucose, insulin, A1C), VO2 max, and sleep quality. He breaks down the research behind each one and why these fundamentals matter more than any supplement stack, peptide, or hormone protocol - plus simple, practical ways to start improving your score today.. . . Watch the episode on YouTube here! Click here to view the episode transcript! Podcast Team Dr. Barrett Deubert - Host Grant Crenshaw - Editor (00:00) - Intro (02:04) - #1: Processed Foods (04:42) - #2: Indoor Air Quality (08:03) - #3: Plastics & Endocrine Disruptors (11:27) - #4: Light & Circadian Rhythm (13:09) - #5: Noise & Stimulation (16:34) - Recap (17:53) - Closing Thoughts DISCLAIMERThis content is strictly the opinion of Dr. Barrett Deubert and is for informational and educational purposes only. It is not intended to provide medical advice or to replace medical advice or treatment from a physician. All viewers of this content are advised to consult their doctors or qualified health professionals regarding health questions and concerns. Neither Dr. Deubert nor the Real Health Co. takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All audience members, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.

Elizabeth Elder knows what it means to carry a lot as a mother. Her two oldest children were born with a rare genetic condition, and in 2021, she lost her daughter Annabelle to complications of that condition at just eleven years old. About a year later, her son Clark, her third child, was diagnosed with Type 1 diabetes at age five. For Elizabeth, who had already spent years navigating the world of medically complex parenting and had even founded a nonprofit to support other moms walking similar roads, the diagnosis felt like one more heavy thing to hold.In this episode, Elizabeth sits down with Risely's Director of Coaching, Abby Cooper, to talk honestly about T1D motherhood: the mom guilt, the pressure to get everything right, and the quiet weight of feeling like your child's numbers are a reflection of you. She shares what shifted when she joined our T1D Mom Coaching Program, from learning that you can't get an A in diabetes, to letting herself receive support for once instead of being the one who always gives it, to the community of moms who are still showing up for each other long after the program ended. It's a moving conversation about grief, grace, and finding a way to carry T1D that leaves room for you to actually live.WHAT WE COVER:Why a stomach bug with no fever was the clue that led to Clark's T1D diagnosis at 5, almost exactly one year after Elizabeth lost her daughterWhat her 5-year-old said to comfort her in the hospital, in the middle of the scariest moment of her yearThe number 1 belief that helped to reduce mom guiltWhy you can't get an A in diabetes, and the reframe that finally freed Elizabeth from treating every A1C like a report cardHow "time in happiness" became just as important as time in range, and the pediatric psychologist who introduced her to itBeing the mom who holds everyone else together, and what it took for her to finally let herself be the one supportedClark's first-ever sleepover 3.5 years after diagnosis, the exact blood sugars Elizabeth watched from home, and how she let him go anywayWHAT'S NEXT:

Failed IVF? Low AMH? High FSH? Told donor eggs? Book a free Functional Fertility Second Opinion before your next fertility decision → fabfertile.com You got eggs. After everything, that part finally went right. Then day one, this many fertilized. Day three, this many are still growing. Then the call where someone tells you none of them made it. And what comes next, almost word for word on call after call, is you going back through your twenties. The years when maybe you weren't taking the best care of yourself. Maybe you drank more, were under a lot of stress, or simply weren't thinking about your fertility yet. And you start wondering, Did I cause this? Is that why this happened? But then you come back to the same thing: I'm healthy now. I'm active. I take care of myself. So what am I missing? Your age is real, and we are not going to ignore it. It usually is not the only thing on the table. In this episode, I walk through the three questions I want answered before you go again. What that cycle actually told us, and what it could not tell us about the 90 days before the injections started. What was investigated and what was not, including the full thyroid panel, triglycerides and insulin rather than A1C alone, hs-CRP, vitamin D absorption, the gut and vaginal microbiome, food sensitivity, and his side beyond a count. And if you do another retrieval, what specifically is changing and why. Preparing is not the same as being evaluated. CHAPTERS 00:00 None of them made it 01:00 About Sarah and the team 01:20 Question 1. What did that cycle actually tell us 02:00 The 90 days before stimulation started 02:30 Preparing is not the same as being evaluated 03:00 Where the nervous system fits 03:30 Question 2. What was investigated and what was not 03:50 Full blood chemistry, thyroid and triglycerides 04:20 hs-CRP, vitamin D absorption and gut infections 04:40 The vaginal and gut microbiome 05:00 Clean eating that may still be driving inflammation 06:00 His side. DNA fragmentation and bloodwork 06:30 The body is not a silo 07:10 What Your Clinic Missed 07:30 Question 3. If you go again, what will actually be different 08:10 Book a Second Opinion with your partner WHAT YOUR CLINIC MISSED If you are not sure what can be investigated or which way to go next, we have a guide called What Your Clinic Missed. It gives you the patterns and themes to look at before you consider your next move. Email hello@fabfertile.ca with MISSED in the subject line. FUNCTIONAL FERTILITY SECOND OPINION Book with your partner and load your labs into the secure portal. We review your bloodwork for patterns your clinic is not set up to examine, and talk through what is worth digging into before another IVF cycle. It is not IVF or your health. It is both. Book your call with your partner here. If you want to know whether the call is right for you first, email hello@fabfertile.ca with FERTILE in the subject line and tell me a little about your situation. ABOUT THE HOST I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. If this episode helped, leave a review. It is how other women find this work.

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Anonymous: Good day Dr.Cabral, your doing great work! Can't imagine how proud your family and team are to have you. My question is regarding elevated CRP (didn't do HS-CRP) just did bloodwork for CRP. Which was 13. Also Lip (a) is 180.. which is high due to genetics. In combination.. A1C is creeping up at 6.1.. I know your not giving health advice however, what foods, products help? Berberine? Omega 3s? Thanks!       Matthew: Hi Dr Cabral-thanks for everything you do. My question is on turmeric. I have seen posts that turmeric supplements, especially those that also contain black pepper, are harmful to the liver. Do you agree? If so, what about turmeric that do not include the black pepper? If turmeric supplement's harm to the liver is higher than the benefit, do you have suggestions on a replacement? Thank you     Jasmine: I think my daughter has Lipedema, I've watched a few of your videos and have researched this topic but have never had this topic addressed: she drinks about a liter and a half of water a day, but doesn't urinate that much, never gets up at night, can go the whole day without. Is this affecting her Lipedema and any info you can share, your ideas/opinions would be appreciated. We do things holistically, no drugs unless absolutely necessary (emergency situations), and I don't think diuretics are the way to go. Thanks for any info, Jasmine       Andrea: Hi Dr. Cabral, What is your opinion of the laser therapy for the brain for improved cognition, lymphatic flow? I was made aware of PBM would love to know your opinion. Thanks for everything, grateful for you!       Anonymous: Good morning Dr.Cabral, How would you go about supporting the body naturally dealing with Hepatitis B (chronic).. This has unfortunately been undetected for years due to being born in East Africa. In turn, this long-term Hep B has lead to Hepatocellular caricoma.. However, after a lot of research, the root cause was the Chronic Hep B.. want to deal with this then support the body to shrink the liver mass. Thoughts? Not asking for medical advice. did the HTMA (was unremarkable) but noticing a bit of itching and upper abdominal pain.         Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!      - - - Show Notes and Resources: StephenCabral.com/3851 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Most people with type 2 diabetes are told it's a forever sentence. Chris Reade was one of them. In 2017, his A1C hit 9.1 with zero warning. He refused medication, did the research, and built a food system around the science of soluble fiber. Six months later, his A1C was 5.5. Seven years later, it has never gone back up. In this episode, entrepreneur and author Chris Reade explains how he reversed a shocking diabetes diagnosis using soluble fiber instead of medication, and why simple, sustainable habits beat extreme diets every time.   RESOURCES: Learn more about Chris Reade here: https://www.beatingdiabetes.us/ Instagram: @beatingdiabetesus Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 00:00 Intro: meet Chris Reade, author of Beating Diabetes 01:13 Sponsor: Peluva Shoes ad 02:59 Chris's diabetes story 03:35 Insurance renewal reveals an A1C of 9.3 06:00 Doctor's grim prognosis and hunting for the cause 09:07 Cancer scare leads to a surprisingly simple fix 11:13 The research: soluble fiber studies since the 1970s 12:19 How soluble fiber controls sugar, weight, and health 17:52 Writing the book: family history and friend Tim's scare 19:41 Frustration with "pills-only" medicine 22:03 Habit stacking, forgiveness, and small daily habits 28:04 Segment: Tara's coaching, app, and retreats 33:00 Soluble vs. insoluble fiber, explained simply 36:34 Continuous glucose monitors: benefits and pitfalls 43:46 His current routine, and "the warranty ends at 30" 44:49 Soapbox: the vegan/carb-fear myth 51:27 Morocco motorcycle trip: eating simply on the road 54:58 Success story: Tim's A1C drops from 13 to normal 56:57 Next-level challenge: cooked-and-cooled resistant starch   WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

GLP-1 receptor agonists have transformed weight loss and metabolic health—but what are we overlooking? In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald is joined by Dr. Sanjay Bhojraj and Dr. Alexis Gonzales to explore the clinical tradeoffs of GLP-1 therapy, including lean muscle preservation, nutrient status, weight regain, and long-term metabolic health. The conversation also examines SiPore, an engineered silica-based intervention that works locally in the GI tract to slow the breakdown and absorption of carbohydrates and fats. Dr. Fitzgerald and her guests discuss findings from the randomized, double-blind, placebo-controlled SHINE trial, including outcomes related to A1c, visceral fat, waist circumference, cholesterol, and lean mass. They also explore how CGMs can reveal post-meal glucose patterns, why muscle preservation matters during weight loss, and how clinicians can support patients transitioning off GLP-1 medications—including those preparing for pregnancy, IVF, or surgery. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Sanjay Bhojraj, MD, FACC is an interventional cardiologist and Fellow of the American Academy of Anti-Aging Medicine specializing in cardiometabolic health, longevity medicine, and precision cardiovascular prevention. He's the founder of the Laguna Institute of Functional Medicine. His programs focus on reversing metabolic dysfunction, improving resilience, and reducing cardiovascular risk through lifestyle optimization and advanced diagnostic testing. Dr. Alexis Gonzales ("Dr. G") is OvationLab's Senior Clinical Implementation and AI Specialist, translating breakthrough research into practical clinical workflows, and holds advanced degrees in biochemistry (Saint Mary's), biotechnology (Johns Hopkins), and naturopathic medicine (Bastyr). She provides concierge functional-medicine care at her private practice in California—focusing on endometriosis, fertility, PCOS, and menopause—while distilling emerging research into practical frameworks at conferences to make integrative solutions accessible. http://sigridpro.com/DRKF THANK YOU TO OUR SPONSOR SIGRID http://sigridpro.com/DRKF *CONNECT with DrKF* Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: https://www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Elias is 10, pre-boluses like a pro, runs a 6.2 A1c, and mentors other kids as a youth ambassador. A bright, funny catch-up a year after his first visit, plus a word with his mom. twiist - A different type of insulin pump has arrived ABLEnow save for today's needs or invest for tomorrow Eversense CGM MiniMed Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Have you been feeling grayed out lately? Numbed up? Like you're going through the motions of your own life but no longer quite feel like yourself? What if that slow, quiet malaise isn't something you have to live with, and what if healing it doesn't require years of work, but simply showing up in the right room, at the right frequency, with the right people? Michael steps outside his usual format to do something he's never done on air before: bring the audience directly into a live group energy healing experience, the same kind of work that's produced what participants are calling miraculous results in his Come Back to Life summer program. From a guided "wall" visualization for shattering limiting beliefs to a full live attunement, this episode is part teaching, part experiential healing session, and part invitation into a small, intimate fall program built entirely around this same energy. This isn't about hoping for a slow, gradual improvement someday. This is about stepping directly into a healing bubble together, right now, and discovering just how much can shift in a single sacred hour. Key Topics: Why the most overlooked kind of healing isn't physical; it's the slow, gray malaise of feeling numbed out and disconnected from your own aliveness. The science behind group healing: Lynne McTaggart's research in The Power of Eight, showing that when a group prays or sets intention for one person, spontaneous healings ripple outward to others in the circle as well. A live group healing circle at Michael's Vermont "mirror pool," setting both a collective healing intention and a deeply personal one for each listener. Why it's essential to ask boldly for what you truly want - not the small, safe version, but the real desire sitting underneath, whether that's physical healing, freedom, abundance, or a life partner. The "wall" visualization: carving your intention into an immovable wall with a magic pen of golden light, then leaping, springs on your feet and all, to the other side, into the life already realized. Why a single anchor word (Michael uses "yes") can instantly return you to a felt sense of your desired future, the same way scent or a hotel key code unlocks something instantly. The origin story of Come Back to Life: how Michael's summer experiment in group energetic healing led to reported miracles - including reduced A1C, resolved back pain, phantom limb pain disappearing, and people coming off pain medication entirely. You don't need to wait for permission to come back to life. The wall you think is holding you back - the diagnosis, the doubt, the "you're too old" or "you'll never", was never as solid as it seemed. Carve your intention into it, leap to the other side, and remember: you are not broken and waiting to be fixed. You are a divine being already whole, simply waiting to reconnect with your own true, healed essence.

Dr. Daniel Chong has spent years helping patients understand their true cardiovascular risk and take meaningful action to prevent heart attacks and strokes.In this episode, Rip and Dr. Chong dig into the confusing, often polarizing world of cholesterol and heart disease. Is LDL cholesterol really important? How low should it go? Is ApoB a better marker? What about calcium scores, lipoprotein(a), statins, saturated fat, and the growing noise around keto and carnivore diets?Dr. Chong offers a grounded, practical, and highly nuanced perspective. He explains why standard LDL cholesterol is only part of the picture, why ApoB and LDL particle number may provide a clearer view of risk, and why cardiovascular disease is never about one single factor. Instead, it is about the full internal environment: inflammation, endothelial function, blood flow, plaque stability, lifestyle, and diet.Rip and Dr. Chong also explore the limits of coronary artery calcium scores, the risks of relying on a “zero” score too early in life, and why soft plaque can still pose a serious threat even when calcified plaque is not detected.They also discuss saturated fat, heme iron, blood viscosity, hydration, testosterone therapy's potential effect on red blood cell count, and the fascinating protective layer inside our blood vessels known as the glycocalyx.This conversation is a reminder that cardiovascular prevention is about building a body that supports vitality from the inside out.You'll Learn:LDL cholesterol matters, but ApoB and LDL particle number may offer a more precise picture of cardiovascular risk.The longer LDL particles remain elevated, the greater the potential risk over time.Saturated fat can interfere with the body's ability to clear LDL particles from the bloodstream.Coronary artery calcium scores can be useful, but they do not detect soft, non-calcified plaque.A calcium score of zero does not always mean “clean arteries,” especially in younger people.Lipoprotein(a), or Lp(a), is an important marker to test at least once.Dr. Chong recommends looking at a broader cardiovascular panel, including lipids, ApoB, Lp(a), A1C, and hs-CRP.Heme iron from red meat is absorbed differently than non-heme iron from plants and may contribute to oxidative stress when elevated.Blood viscosity — or how “thick” your blood is — can influence endothelial function and plaque formation.Hydration, plant foods, and, in some cases, blood donation may help support healthier blood viscosity.The glycocalyx is a delicate, hair-like protective layer that supports endothelial function.A whole food, plant-based lifestyle remains one of the most powerful foundations for vascular health.Learn More About our 2026 Live PLANTSTRONG Events: https://plantstrongevents.com/ Let Us Help Your PLANTSTRONG JourneyLearn More About Our Corporate Wellness Program: https://liveplantstrong.com/corporate-wellness/ COMPLEMENT: Use code PLANTSTRONG for 30% off at https://lovecomplement.com/pages/plantstrong-special-offer Follow PLANTSTRONG and Rip Esselstynhttps://plantstrong.com/ https://www.facebook.com/GoPlantstrong https://www.instagram.com/goplantstrong/https://www.instagram.com/ripesselstyn/ Follow the PLANTSTRONG Podcast and Give the Show a 5-star RatingApple PodcastsSpotifyWatch on YouTubeEpisode Webpage